Processing 00000000.tx.1: Oxidative Stress-mediated, Post-translational Loss of MafA Protein as a Contributing Mechanism to Loss of Insulin Gene Expression in Glucotoxic Beta Cells* Jamie S. 

Phrase: "Oxidative Stress-mediated, Post-translational Loss of MafA Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1517945:Loss [Quantitative Concept]

Phrase: "as a Contributing Mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "to Loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of Insulin Gene Expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Glucotoxic Beta Cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   867   C0030281:Beta cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "* Jamie S."
Processing 00000000.tx.2: Harmon, Roland Stein, and R. 

Phrase: "Harmon,"

Phrase: "Roland Stein,"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: Paul Robertson|| From the Pacific Northwest Research Institute, Seattle, Washington 98122, the Departments of Medicine and Pharmacology, University of Washington, Seattle, Washington 98195, and the Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee 37232 Received for publication, September 9, 2004 , and in revised form, December 23, 2004.  

Phrase: "Paul Robertson||"

Phrase: "From the Pacific Northwest Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035172:Research Institute [Organization]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Seattle,"

Phrase: "Washington 98122,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:Washington [Geographic Area]

Phrase: "the Departments of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "University of Washington,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0043038:Washington [Geographic Area]

Phrase: "Seattle,"

Phrase: "Washington 98195,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:Washington [Geographic Area]

Phrase: "and"

Phrase: "the Department of Molecular Physiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Biophysics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005553:Biophysics [Biomedical Occupation or Discipline]

Phrase: "Vanderbilt University Medical Center,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0041740:University [Manufactured Object,Organization]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: "Nashville,"

Phrase: "Tennessee 37232"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039514:Tennessee [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "September 9,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "December 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "2004."
Processing 00000000.tx.4: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Glucose toxicity in pancreatic islet beta cells causes loss of insulin gene expression, content, and secretion due to loss of binding of transcription factors, most notably PDX-1 and RIPE-3b1 activator, to the promoter region of the insulin gene. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Glucose toxicity in pancreatic islet beta cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040539:toxicity [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "loss of insulin gene expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "secretion due to loss of binding of transcription factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]

Phrase: "most notably PDX-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1425057:MOST-1 [Gene or Genome]
   861   C1826562:PDX-1 [Gene or Genome]
   812   C0205393:Most [Quantitative Concept]
   812   C0332134:PDX [Qualitative Concept]
   812   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "RIPE-3b1 activator,"

Phrase: "to the promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the insulin gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1337112:Insulin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.5: Recently, RIPE-3b1 activator was cloned and identified as the mammalian homologue of avian MafA/Maf-L (MafA). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "RIPE-3b1 activator"

Phrase: "was"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "identified as the mammalian homologue of avian MafA/Maf-L (MafA"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   754   C1416687:MAFA-L [Gene or Genome]
           MAFA
   738   C0005595:Avian [Bird]
   738   C0024660:Mammalian [Mammal]
   738   C0205396:Identified [Qualitative Concept]
   738   C1334043:Homologue [Gene or Genome]
   738   C1427946:MAFA [Gene or Genome]
   738   C1550043:Identified [Finding]
   738   C1551388:Identified [Functional Concept]

Phrase: ")."
Processing 00000000.tx.6: This enabled us to carry out more extensive studies of the role of MafA in glucotoxicity than were hitherto possible. 

Phrase: "This enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "out more extensive studies of the role of MafA"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0947630:studies [Laboratory Procedure]
   708 E C0557651:Study [Manufactured Object]
   708 E C2603343:Study [Research Activity]

Phrase: "in glucotoxicity"

Phrase: "than"

Phrase: "were"

Phrase: "hitherto possible."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]
Processing 00000000.tx.7: Northern analysis of glucotoxic HIT-T15 cells revealed normal amounts of MafA mRNA, but Western analysis demonstrated a 97  1% reduction in MafA protein (p < 0.0001). 

Phrase: "Northern analysis of glucotoxic HIT-T15 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "normal amounts of MafA mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "but"

Phrase: "Western analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "demonstrated"

Phrase: "a 97  1% reduction in MafA protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(p < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.8: The proteasome is a likely site for MafA degradation as lactacystin, an irreversible proteasome inhibitor, caused an accumulation of MafA protein. 

Phrase: "The proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "a likely site for MafA degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "as lactacystin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "an irreversible proteasome inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   901   C2266856:Proteasome Inhibitor [Molecular Function]
   901   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an accumulation of MafA protein."
Processing 00000000.tx.9: Antioxidants have previously been shown to prevent the adverse effects of glucose toxicity on beta cell function both in vivo and in vitro.In the current study, chronic culturing of HIT-T15 cells with the antioxidant N-acetylcysteine (NAC) prevented loss of MafA protein (late passage = 18.9  10.4% of early passage, p < 0.001; late passage with NAC = 68.7  19.7% of early passage, p = not significant) and loss of DNA binding (late passage = 63.7  9% of early passage, p < 0.02; late passage with NAC = 116  10% of early passage, p = not significant). 

Phrase: "Antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "have"

Phrase: "previously"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the adverse effects of glucose toxicity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0001688:adverse effects [Functional Concept]
   790   C0879626:Adverse effects [Pathologic Function]
   767   C1158774:glucose effect [Genetic Function]
   756 E C0559546:Adverse Effect [Finding]
   753   C1280500:effects [Qualitative Concept]
   731   C0600688:Toxic effect [Injury or Poisoning]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on beta cell function"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   901   C0007613:Cell Function [Cell Function]
   901   C0030281:Beta cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   827   C2004068:Beta [Qualitative Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "chronic culturing of HIT-T15 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0007585:cells culture [Laboratory Procedure]
   767   C0007635:cell culturing [Cell]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "with the antioxidant N-acetylcysteine (NAC) prevented loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1517945:Loss [Quantitative Concept]

Phrase: "of MafA protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(late passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "= 18.9  10.4% of early passage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439799:Passage [Spatial Concept]
   748   C1279919:Early [Temporal Concept]

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; late passage with NAC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439799:Passage [Spatial Concept]

Phrase: "= 68.7  19.7% of early passage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439799:Passage [Spatial Concept]
   748   C0450387:68 [Intellectual Product]
   748   C1279919:Early [Temporal Concept]

Phrase: "p ="
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "loss of DNA binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "(late passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "= 63.7  9% of early passage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439799:Passage [Spatial Concept]
   753   C1279919:Early [Temporal Concept]

Phrase: "p < 0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; late passage with NAC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439799:Passage [Spatial Concept]

Phrase: "= 116  10% of early passage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439799:Passage [Spatial Concept]
   760   C1279919:Early [Temporal Concept]

Phrase: "p ="
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "not significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.10: Additionally, transient transfection of PDX-1 or MafA cDNA into glucotoxic cells increased PDX-1 and MafA protein levels and individually increased insulin promoter activity (untreated = 34%, PDX-1 = 70%, MafA = 78%; percentage of activity of early passage cells), whereas the combined transfection of MafA and PDX-1 completely restored insulin promoter activity. 

Phrase: "Additionally,"

Phrase: "transient transfection of PDX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "or"

Phrase: "MafA cDNA into glucotoxic cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "MafA protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "individually increased insulin promoter activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0474395:increased activity [Finding]
   853   C1145751:insulin activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "(untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "= 34%,"

Phrase: "PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "= 70%,"

Phrase: "MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "= 78%"

Phrase: "; percentage of activity of early passage cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the combined transfection of MafA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "PDX-1 completely restored insulin promoter activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C1145751:insulin activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.11: This recovery of promoter activity following transient transfection had no effect on endogenous insulin mRNA. 

Phrase: "This recovery of promoter activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237820:Recovery [Activity]
   760   C1555688:recovery [Idea or Concept]
   760   C2004454:Recovery [Organism Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "had"

Phrase: "no effect on endogenous insulin mRNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.12: However, adenoviral infection of MafA and PDX-1 significantly increased endogenous insulin mRNA levels by 93% (121  9 versus 233  18 density light units; n = 5, p < 0.001). 

Phrase: "However,"

Phrase: "adenoviral infection of MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0851887:adenoviral infection [Disease or Syndrome]
   770   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "and"

Phrase: "PDX-1 significantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1826562:PDX-1 [Gene or Genome]
   827   C0332134:PDX [Qualitative Concept]
   827   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "endogenous insulin mRNA levels by 93%"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0202098:insulin levels [Laboratory Procedure]
   783   C0428405:insulin levels [Laboratory or Test Result]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(121  9"

Phrase: "versus"

Phrase: "233  18 density light units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0439148:Units [Quantitative Concept]
   804   C1519795:Units [Quantitative Concept]
   771 E C1704753:Unit [Manufactured Object]
   771 E C1880519:Unit [Quantitative Concept]

Phrase: "; n = 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.13: We conclude that the absence of MafA protein from beta cells via chronic oxidative stress contributes importantly to the loss of endogenous insulin gene expression as glucose toxicity develops.  

Phrase: "We"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the absence of MafA protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "from beta cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "via chronic oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "importantly to the loss of endogenous insulin gene expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0017262:Gene Expression [Genetic Function]
   764   C1337112:Insulin Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205227:Endogenous [Functional Concept]
   742   C1517945:Loss [Quantitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]

Phrase: "as glucose toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "develops."
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  After the onset of type 2 diabetes, chronic hyperglycemia causes glucotoxic changes in many tissues (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES  After the onset of type 2 diabetes,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   770   C0441730:Type 2 [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C1514811:Reference [Idea or Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1706462:Reference [Conceptual Entity]

Phrase: "chronic hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0342300:Chronic hyperglycaemia [Pathologic Function]
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "glucotoxic changes in many tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: Glucose toxicity in the pancreatic islet beta cell secondarily leads to further defects in beta cell function, including decreases in insulin reporter activity, gene expression, content, and secretion (3). 

Phrase: "Glucose toxicity in the pancreatic islet beta cell secondarily"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0040539:toxicity [Qualitative Concept]
   742   C0600688:Toxicity [Injury or Poisoning]

Phrase: "leads to further defects"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0243067:defects [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1517331:Further [Spatial Concept]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737 E C0205108:far [Spatial Concept]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in beta cell function,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   901   C0007613:Cell Function [Cell Function]
   901   C0030281:Beta cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   827   C2004068:Beta [Qualitative Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "decreases in insulin reporter activity,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0547047:decreases [Quantitative Concept]
   726 E C0392756:Decrease [Qualitative Concept]

Phrase: "gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Antioxidants have been shown to prevent these adverse changes in experimental models (4, 5). 

Phrase: "Antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "these adverse changes in experimental models"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.17: We previously observed that loss of insulin gene expression is accompanied by decreased binding to the promoter region of two important transcription factors, PDX-1 1 (STF-1, IDX-1, IPF-1) and RIPE-3b1 activator (68). 

Phrase: "We previously"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that loss of insulin gene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "accompanied by decreased binding"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "to the promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017446:Region [Geographic Area]
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of two important transcription factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "PDX-1 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1826562:PDX-1 [Gene or Genome]
   827   C0332134:PDX [Qualitative Concept]
   827   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "(STF-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0171961:STF-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1826562:STF-1 [Gene or Genome]
   861   C0599939:STF [Amino Acid, Peptide, or Protein,Hormone,Immunologic Factor]

Phrase: "IDX-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1826562:IDX-1 [Gene or Genome]

Phrase: "IPF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1800706:IPF [Disease or Syndrome]

Phrase: ")"

Phrase: "and"

Phrase: "RIPE-3b1 activator"

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.18: PDX-1 is required for pancreatic development and is a key regulator of insulin gene expression. 

Phrase: "PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "required for pancreatic development"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1514873:Required [Functional Concept]
   770   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "a key regulator of insulin gene expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0017362:Regulator Gene [Gene or Genome]
   748   C0182953:REGULATOR [Medical Device]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.19: Mutations within the RIPE-3b1/C1 element of the insulin promoter markedly reduce glucose-responsive insulin gene expression (7). 

Phrase: "Mutations within the RIPE-3b1/C1 element of the insulin promoter markedly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C0026882:Mutations [Genetic Function]
   703 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "reduce"

Phrase: "glucose-responsive insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0017262:Gene Expression [Genetic Function]
   840   C1337112:Insulin Gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.20: We also reported that loss of RIPE-3b1 binding precedes the loss of PDX-1 binding to the insulin promoter as glucotoxicity develops (8). 

Phrase: "We also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that loss of RIPE-3b1 binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "precedes"

Phrase: "the loss of PDX-1 binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "to the insulin promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as glucotoxicity"

Phrase: "develops"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.21: The chronology of these losses is likely to be important in light of a recent report that RIPE-3b1/MafA directly activates PDX-1 transcription (9). 

Phrase: "The chronology of these losses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0008717:Chronology [Intellectual Product]
   760   C0600642:Chronology [Intellectual Product]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "important in light of a recent"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that RIPE-3b1/MafA directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1416687:MAFA [Gene or Genome]
   812   C1427946:MAFA [Gene or Genome]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "PDX-1 transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040649:Transcription [Genetic Function]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.22: The work in this study features the use of HIT-T15 cells, a glucose-responsive beta cell line that has proven over the past decade to reproduce the molecular changes in gene expression that are caused by glucose toxicity in vivo in animal models. 

Phrase: "The work in this study"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043227:Work [Occupational Activity]

Phrase: "features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521970:Feature [Qualitative Concept]
  1000   C1706388:Feature [Conceptual Entity]
  1000   C2346469:Feature [Qualitative Concept]
  1000   C2348519:Feature [Qualitative Concept]

Phrase: "the use of HIT-T15 cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "a glucose-responsive beta cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0007600:Cell Line [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]

Phrase: "that"

Phrase: "has"

Phrase: "proven over the past decade to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0456369:Proven [Qualitative Concept]
   753   C1444637:Past [Temporal Concept]
   753   C2981279:Decade [Quantitative Concept]

Phrase: "reproduce"

Phrase: "the molecular changes in gene expression"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0025320:The change [Physiologic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "caused by glucose toxicity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "in vivo in animal models."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1515657:In Vivo Model [Research Activity]
   806   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.23: Since isolated islets cannot be chronically cultured to study the adverse effects of high glucose concentrations over many months, this cell line is a valuable surrogate. 

Phrase: "Since isolated islets"

Phrase: "cannot"

Phrase: "be"

Phrase: "chronically"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the adverse effects of high glucose concentrations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   778   C0001688:adverse effects [Functional Concept]
   778   C0879626:Adverse effects [Pathologic Function]
   757   C1158774:glucose effect [Genetic Function]
   748   C1280500:effects [Qualitative Concept]
   745 E C0559546:Adverse Effect [Finding]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "over many months,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439231:months [Temporal Concept]
   966 E C0439507:/month [Temporal Concept]

Phrase: "this cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "a valuable surrogate."
Processing 00000000.tx.24: In our previous work, reconstitution of late passage glucotoxic HIT-T15 cells by transient transfection with PDX-1 partially restored insulin promoter activity (8). 

Phrase: "In our previous work,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "reconstitution of late passage glucotoxic HIT-T15 cells"

Phrase: "by transient transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with PDX-1 partially restored insulin promoter activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C1145751:insulin activity [Molecular Function]
   795   C0205177:Activity [Functional Concept]
   795   C0439167:% activity [Quantitative Concept]
   795   C0441655:Activity [Activity]
   795   C1561536:*Activity [Idea or Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.25: Since RIPE-3b1 had not yet been cloned, we were unable to extend our studies with this transcription factor but hypothesized that reconstitution of the cells with both PDX-1 and RIPE-3b1 activator would lead to greater recovery of insulin promoter activity. 

Phrase: "Since"

Phrase: "RIPE-3b1"

Phrase: "had"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: ","

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "our studies with this transcription factor"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "but"

Phrase: "hypothesized"

Phrase: "that reconstitution of the cells"

Phrase: "with both PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "RIPE-3b1 activator"

Phrase: "would"

Phrase: "lead to greater recovery of insulin promoter activity."
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   767   C1145751:insulin activity [Molecular Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205177:Activity [Functional Concept]
   744   C0237820:Recovery [Activity]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0443228:greater [Quantitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1555688:recovery [Idea or Concept]
   744   C1561536:*Activity [Idea or Concept]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1704243:Greater [Quantitative Concept]
   744   C2004454:Recovery [Organism Function]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   711 E C0549177:Great [Quantitative Concept]
Processing 00000000.tx.26: With the recent cloning and identification of RIPE-3b1 activator as MafA (1012), we have been able to perform new studies to examine 1) whether levels of MafA mRNA and protein are decreased in glucotoxic beta cells; 

Phrase: "With the recent cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "identification of RIPE-3b1 activator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "as MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "(1012"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "been"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "new studies to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "examine"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "whether"

Phrase: "levels of MafA mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "decreased in glucotoxic beta cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   773   C0030281:Beta cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0330390:Beta [Plant]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0439096:Beta [Intellectual Product]
   760   C0442797:decreased [Qualitative Concept]
   760   C2004068:Beta [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C0547047:Decrease [Quantitative Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.27: 2) the mechanism of MafA protein degradation; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "the mechanism of MafA protein degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.28: 3) whether the antioxidant, N-acetylcysteine, can prevent glucotoxicity-induced loss of MafA protein and binding to the insulin promoter; 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "whether"

Phrase: "the antioxidant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "N-acetylcysteine,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "can"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "glucotoxicity-induced loss of MafA protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "binding to the insulin promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1623517:insulin binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.29: and 4) whether overexpression of MafA and PDX-1 together can restore insulin promoter activity and mRNA levels more fully than PDX-1 alone.  

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "whether"

Phrase: "overexpression of MafA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "PDX-1 together"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1826562:PDX-1 [Gene or Genome]
   827   C0332134:PDX [Qualitative Concept]
   827   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   827   C1883357:Together [Qualitative Concept]

Phrase: "can"

Phrase: "restore"

Phrase: "insulin promoter activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1145751:insulin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "mRNA levels more fully than PDX-1 alone."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C1826562:PDX-1 [Gene or Genome]
   750   C0456947:Level 1 [Intellectual Product]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0205171:Alone [Quantitative Concept]
   744   C0332134:PDX [Qualitative Concept]
   744   C0439044:alone [Finding]
   744   C0441889:Levels [Qualitative Concept]
   744   C0679994:alone [Group Attribute]
   744   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.30: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Cell CultureHIT-T15 cells were maintained in RPMI 1640 media containing 10% fetal bovine serum and 11.1 mM glucose as described previously (13). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell CultureHIT-T15 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]

Phrase: "were"

Phrase: "maintained in RPMI 1640 media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   760   C1314677:Maintained [Functional Concept]
   726 E C0024501:Maintain [Activity]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "11.1 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.31: Cells were categorized as early passage (p7175) or late passage (p123128), with each passage occurring weekly. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "categorized as early passage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439799:Passage [Spatial Concept]
   770   C0871968:categorized [Activity]
   770   C1279919:Early [Temporal Concept]

Phrase: "(p7175"

Phrase: ")"

Phrase: "or"

Phrase: "late passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "(p123128"

Phrase: ")"

Phrase: ","

Phrase: "with each passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439799:Passage [Spatial Concept]

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "weekly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332174:Weekly [Temporal Concept]
Processing 00000000.tx.32: Chronic culturing of HIT-T15 cells with N-acetyl-L-cysteine (Sigma; 0.5, 1, or 5 mM) added to the media was begun at p70. 

Phrase: "Chronic culturing of HIT-T15 cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0007585:cells culture [Laboratory Procedure]
   767   C0007635:cell culturing [Cell]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "with N-acetyl-L-cysteine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "; 0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "5 mM)"

Phrase: "added to the media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1524062:Added [Functional Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C1883712:Add [Functional Concept]
   737 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "begun at p70."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0753627:P70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1705582:P70 [Gene or Genome]
   790   C1836606:p70 [Gene or Genome]
   756   C0439659:Begin [Temporal Concept]
Processing 00000000.tx.33: Western and Northern Blot AnalysesNuclear extracts were prepared by the method of Schreiber et al. 

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "Northern Blot AnalysesNuclear extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared by the method of Schreiber et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
   711   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.34: (14) with buffers containing 1x phosphatase inhibitor mixture set II (Calbiochem), 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 1 ng/l aprotinin, 10 ng/l leupeptin. 

Phrase: "(14"

Phrase: ")"

Phrase: "with buffers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1x phosphatase inhibitor mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439962:Mixture [Substance]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "II"

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: ","

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "0.5 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 ng/l aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "10 ng/l leupeptin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.35: Protein concentrations were determined by the BCA assay (Pierce). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by the BCA assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1332420:bca [Gene or Genome]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.36: Nuclear extracts (10 g) were separated on 10% polyacrylamide Ready gels (Bio-Rad) and electrotransferred onto Trans-blot nitrocellulose membranes (Bio-Rad). 

Phrase: "Nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "(10 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "separated on 10% polyacrylamide Ready gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   719 E C1382104:Gel [Substance]

Phrase: "(Bio-Rad)"

Phrase: "and"

Phrase: "electrotransferred onto Trans-blot nitrocellulose membranes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0025255:Membranes [Tissue]
   753   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   753   C2826298:TRANS [Idea or Concept]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]

Phrase: "(Bio-Rad"

Phrase: ")."
Processing 00000000.tx.37: Membranes were immunoblotted with mouse MafA antisera (1:10,000) (Bethyl Laboratories) or mouse PDX-1 antisera (1:3000) (gift from Dr. Chris Wright, Vanderbilt University) overnight at 4 C in 5% nonfat dry milk in phosphate-buffered saline with 0.5% Tween. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "immunoblotted with mouse MafA antisera"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C1416687:MAFA [Gene or Genome]
   760   C1427946:MAFA [Gene or Genome]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: ")"

Phrase: "(Bethyl Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "mouse PDX-1 antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "3000"

Phrase: ")"

Phrase: "(gift from Dr. Chris Wright,"

Phrase: "Vanderbilt University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "overnight at 4 C in 5% nonfat dry milk"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0011682:Dry [Natural Phenomenon or Process]
   742   C0026131:Milk [Body Substance]
   742   C0205222:Dry [Qualitative Concept]
   742   C0349374:Milk [Food]
   742   C0439583:Overnight [Temporal Concept]
   742   C0444318:Milk [Substance]
   742   C1512080:Dry [Qualitative Concept]
   742   C2825079:Milk [Food]

Phrase: "in phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "with 0.5% Tween."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   771 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   734   C0444499:0/5 [Quantitative Concept]
Processing 00000000.tx.38: The membranes were washed and probed with anti-rabbit IgG (1:4000) (Jackson ImmunoResearch Laboratories) for 1 h at room temperature. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "probed with anti-rabbit IgG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0034493:Rabbit [Mammal]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "4000"

Phrase: ")"

Phrase: "(Jackson ImmunoResearch Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.39: MafA and PDX-1 proteins were detected using the ECL Western blotting detection kit (Amersham Biosciences). 

Phrase: "MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "and"

Phrase: "PDX-1 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ECL Western blotting detection kit (Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.40: Membranes were stripped and reprobed with anti-TFIID (N-12) (1:200) (Santa Cruz Biotechnology) to control for protein loading. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "stripped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1321564:Strip [Medical Device]

Phrase: "and"

Phrase: "reprobed with anti-TFIID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0076919:TFIID [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1337106:TFIID [Gene or Genome]

Phrase: "(N-12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "(Santa Cruz Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for protein loading."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1708715:Loading [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.41: Peptide neutralization was performed to ensure MafA antibody specificity in HIT-T15 cells (data not shown). 

Phrase: "Peptide neutralization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1578828:Neutralization [Laboratory Procedure]
   861   C2987668:Neutralization [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "MafA antibody specificity in HIT-T15 cells"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0003264:Antibody Specificity [Molecular Function]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]
   738 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.42: Densitometry of autoradiograms was performed using OptiQuant image analysis software (Packard). 

Phrase: "Densitometry of autoradiograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0011321:Densitometry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "OptiQuant image analysis software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Packard"

Phrase: ")."
Processing 00000000.tx.43: Total RNA was extracted using the RNeasy mini kit (Qiagen). 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the RNeasy mini kit (Qiagen"

Phrase: ")."
Processing 00000000.tx.44: MafA mRNA levels were determined by Northern blot analysis using the NorthernMax system (Ambion) with slight modification to the manufacturer's instructions. 

Phrase: "MafA mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by Northern blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   806   C1621557:Northern Blot [Research Device]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1709269:Northern [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the NorthernMax system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Ambion"

Phrase: ")"

Phrase: "with slight modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.45: The RNA was electrotransferred to a nylon membrane for 2 h in 1x Tris acetate/EDTA buffer. 

Phrase: "The RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "electrotransferred to a nylon membrane"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025255:Membrane [Tissue]
   760   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   760   C0596901:Membrane [Cell Component]
   760   C0740034:Nylon [Biomedical or Dental Material]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in 1x Tris acetate/EDTA buffer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   937   C0758986:tris-acetate-EDTA buffer [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   875   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.46: Prehybridization at 42 C for 1 h with ULTRAhyb-Oligo (Ambion) was followed by a 16-h hybridization with a -32P end-labeled mouse MafA cDNA probe 611CACCACCACGGAGGCTCTGGCCACCACGGCGGAGGCGCGGGTCACGGCGG661. 

Phrase: "Prehybridization at 42 C"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with ULTRAhyb-Oligo (Ambion"

Phrase: ")"

Phrase: "was"

Phrase: "followed by a 16-h hybridization"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0020202:Hybridisation [Genetic Function]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1300517:Hybridization [Laboratory Procedure]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "with a -32P end-labeled mouse MafA cDNA probe 611CACCACCACGGAGGCTCTGGCCACCACGGCGGAGGCGCGGGTCACGGCGG661."
Processing 00000000.tx.47: Blots were washed according to manufacturer's instructions. 

Phrase: "Blots"

Phrase: "were"

Phrase: "washed according to manufacturer's instructions."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0302828:instructions [Intellectual Product]
   760   C0680240:according [Social Behavior]
   760   C0947322:Manufacturer [Intellectual Product]
   760   C1442085:Instructions [Idea or Concept]
   760   C1548982:Washed [Idea or Concept]
   760   C1705426:Manufacturer [Population Group]
   760   C3263700:Instructions [Clinical Attribute]
   726 E C0039401:Instruction [Educational Activity]
   726 E C0441648:Wash [Activity]
Processing 00000000.tx.48: Detection of mRNA levels was performed using the Cyclone storage phosphor system (Packard), and densitometry was performed using the OptiQuant image analysis software (Packard). 

Phrase: "Detection of mRNA levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Cyclone storage phosphor system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Packard"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the OptiQuant image analysis software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Packard"

Phrase: ")."
Processing 00000000.tx.49: ImmunoprecipitationEarly passage HIT-T15 cells were cultured in RPMI media containing 0.8 mM glucose for 5 days. 

Phrase: "ImmunoprecipitationEarly passage HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured in RPMI media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   802   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737   C2242979:Culture [Laboratory Procedure]
   737 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.8 mM glucose for 5 days."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.50: The cells were then subcultured for 72 h in RPMI media containing either 11.1 or 0.8 mM glucose. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subcultured for 72 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0200940:Subculture [Laboratory Procedure]
   737   C0699799:subculture [Population Group]

Phrase: "in RPMI media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either 11.1"

Phrase: "or"

Phrase: "0.8 mM glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.51: Lactacystin (Sigma), at a final concentration of 10 M, was added during the last 12 h of the subculture period to inhibit proteasome function. 

Phrase: "Lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "at a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "added during the last 12 h of the subculture period to"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   738   C0033727:H+ [Element, Ion, or Isotope]
   738   C0200940:Subculture [Laboratory Procedure]
   738   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0439531:/period [Temporal Concept]
   738   C0441932:H+ [Classification]
   738   C0564385:/h [Quantitative Concept]
   738   C0699799:subculture [Population Group]
   738   C1524062:Added [Functional Concept]
   738   C1948053:Period [Temporal Concept]
   704 E C1883712:Add [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "proteasome function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.52: Whole cell extracts were obtained by harvesting cells in lysis buffer (140 mM NaCl, 10 mM Tris, pH 7.4, 1 mM CaCl2, 1 mM MgCl2, 10% glycerol, 1% Nonidet P-40, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 2 ng/l aprotinin, 10 ng/l leupeptin). 

Phrase: "Whole cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "obtained by harvesting cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1512335:Harvest [Health Care Activity]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "in lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(140 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "10 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1 mM CaCl2,"

Phrase: "1 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "0.5 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "2 ng/l aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "10 ng/l leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.53: Total MafA protein levels were measured by Western blot analysis using 30 g of protein and immunoblotted as described above. 

Phrase: "Total MafA protein levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   875   C0555903:Total protein [Laboratory Procedure]
   875   C1261360:total protein [Laboratory or Test Result]
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by Western blot analysis"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "30 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "immunoblotted as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   737   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.54: To determine the level of MafA ubiquitination, 500 g of cellular lysate was diluted in 500 l of phosphate-buffered saline. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the level of MafA ubiquitination,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "500 g of cellular lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "diluted in 500 l of phosphate-buffered saline."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0036082:Saline [Substance]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   711   C1720119:Dilute [Functional Concept]
   711   C1948037:Dilute [Functional Concept]
Processing 00000000.tx.55: Immunocomplexes were formed by the addition of 2 g of MafA antibody with gentle rocking overnight at 4 C. 

Phrase: "Immunocomplexes"

Phrase: "were"

Phrase: "formed by the addition of 2 g of MafA antibody"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   757   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0205431:Formed [Functional Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C1416687:MAFA [Gene or Genome]
   739   C1427946:MAFA [Gene or Genome]
   739   C1883712:Addition [Functional Concept]
   706 E C0348078:Form [Qualitative Concept]
   706 E C0376315:Form [Manufactured Object]
   706 E C1522492:Form [Functional Concept]

Phrase: "with gentle rocking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005899:Rocking [Individual Behavior]

Phrase: "overnight at 4 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.56: These complexes were precipitated with 25 l of protein G agarose (Upstate Biotechnology) for 2 h at 4 C with gentle rocking. 

Phrase: "These complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "precipitated with 25 l of protein G agarose"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0060916:protein g [Amino Acid, Peptide, or Protein]
   767 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0439294:g l [Quantitative Concept]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0036681:Agarose [Carbohydrate]
   744   C0439267:g% [Quantitative Concept]
   711   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "(Upstate Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C"

Phrase: "with gentle rocking."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005899:Rocking [Individual Behavior]
Processing 00000000.tx.57: The immunocomplexes were washed three times with phosphate-buffered saline and subjected to immunoblot analysis on 10% polyacrylamide Ready gels (Bio-Rad). 

Phrase: "The immunocomplexes"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with phosphate-buffered saline"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "on 10% polyacrylamide Ready gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "(Bio-Rad"

Phrase: ")."
Processing 00000000.tx.58: Membranes were immunoblotted with anti-ubiquitin (1:1000) (Calbiochem) overnight. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "immunoblotted with anti-ubiquitin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.59: Membranes were washed and probed with anti-mouse IgG (1:1000) (Jackson ImmunoResearch Laboratories) for 1 h at room temperature. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "probed with anti-mouse IgG (1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "(Jackson ImmunoResearch Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.60: Detection and densitometry were performed as above. 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]

Phrase: "were"

Phrase: "performed as above."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.61: Transient TransfectionHIT-T15 cells were subcultured for 48 h in 12-well culture plates, 0.65 x 106 cells/well. 

Phrase: "Transient TransfectionHIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subcultured for 48 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0200940:Subculture [Laboratory Procedure]
   737   C0699799:subculture [Population Group]

Phrase: "in 12-well culture plates,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0180454:culture plates [Medical Device]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1139930:plates [Medical Device]
   812   C2242979:Culture [Laboratory Procedure]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]

Phrase: "0.65 x 106 cells/well."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C2347578:Cells/well [Quantitative Concept]
   799   C0007634:Cells [Cell]
   799   C0205170:Well [Qualitative Concept]
   799   C0450385:65 [Intellectual Product]
   799   C3146287:Well [Manufactured Object]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.62: The cells were washed with serum-free media and transfected with Lipofectamine reagent (Invitrogen) according to the manufacturer's instructions. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with serum-free media"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   862   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C1254021:Media [Tissue]
   760   C1546774:Serum [Intellectual Product]
   760   C1548982:Washed [Idea or Concept]
   760   C1550100:Serum [Body Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C0441648:Wash [Activity]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "transfected with Lipofectamine reagent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.63: Each well contained 800 l of serum-free media with 5 g of Lipofectamine reagent, 11.25 g of Plus reagent (Invitrogen), 0.5 g of INS-LUC, the human insulin gene sequence 326 to +30 linked to a luciferase reporter gene (gift from Dr. Danielle Melloul, Hadassah University Hospital), 10 ng of pRL-CMV (Promega), and empty CMV4 vector to make the total DNA concentration equivalent among all wells. 

Phrase: "Each well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "800 l of serum-free media"

Phrase: "with 5 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of Lipofectamine reagent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "11.25 g of Plus reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "0.5 g of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "INS-LUC,"

Phrase: "the human insulin gene sequence 326 to +30"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   829   C0314604:Human gene [Gene or Genome]
   818   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   818   C1337112:Insulin Gene [Gene or Genome]
   795   C0004793:Sequence [Nucleotide Sequence]
   795   C0017337:Gene [Gene or Genome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0086418:Human [Human]
   795   C0162326:Sequence [Nucleotide Sequence]
   795   C0162327:Sequence [Nucleotide Sequence]
   795   C1519249:Sequence [Functional Concept]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   724 E C1548958:Sequential [Idea or Concept]
   724 E C1705294:Sequential [Qualitative Concept]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "linked to a luciferase reporter gene"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0206414:Reporter Gene [Gene or Genome]
   783   C0314613:Linked gene [Genetic Function]
   783   C1334435:Luciferase Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0335038:Reporter [Professional or Occupational Group]
   753   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   753   C1705915:Reporter [Conceptual Entity]
   753   C1709908:Reporter [Group]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "(gift from Dr. Danielle Melloul,"

Phrase: "Hadassah University Hospital"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "10 ng of pRL-CMV (Promega"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "empty CMV4 vector to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vector [Spatial Concept]
   812   C1705099:Vector [Idea or Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the total DNA concentration equivalent among all wells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205163:Equivalent [Qualitative Concept]
   744   C0439185:equivalent [Quantitative Concept]
Processing 00000000.tx.64: Some wells also contained PDX-1 cDNA, MafA cDNA, or both. 

Phrase: "Some wells also contained PDX-1 cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "MafA cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "both."
Processing 00000000.tx.65: Four hours after transfection, media was replaced with RPMI 1640 containing 10% fetal bovine serum. 

Phrase: "Four hours after transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with RPMI 1640"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
Processing 00000000.tx.66: Cells were harvested 2430 h later with passive lysis buffer (Promega), and luciferase activities were determined using the Dual-Luciferase assay kit (Promega) according to the manufacturer's instructions. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "2430 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "later with passive lysis buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205087:Late [Temporal Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "luciferase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1151115:luciferase activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Dual-Luciferase assay kit (Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0072149:Promega [Lipid]

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.67: Data are expressed as INS-LUC activity (firefly luciferase) divided by pRL-CMV activity (Renilla luciferase) to control for transfection efficiency among the different conditions. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as"

Phrase: "INS-LUC activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(firefly luciferase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   861   C0162328:Firefly [Eukaryote]

Phrase: ")"

Phrase: "divided by pRL-CMV activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205177:Activity [Functional Concept]
   760   C0332849:Divided [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(Renilla luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for transfection efficiency"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0013682:Efficiency [Quantitative Concept]
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "among the different conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.68: Adenovirus InfectionAdenoviruses were obtained from the Pacific Northwest Research Institute Adenoviral Core (provided by Dr. Christopher J. Rhodes). 

Phrase: "Adenovirus InfectionAdenoviruses"

Phrase: "were"

Phrase: "obtained from the Pacific Northwest Research Institute Adenoviral Core"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   764   C0030170:Pacific Northwest [Geographic Area]
   764   C0035172:Research Institute [Organization]
   742   C0001483:Adenoviral [Virus]
   742   C0021622:institute [Organization]
   742   C0035168:research [Research Activity]
   742   C0242481:Research [Research Activity]
   742   C0444669:Core [Spatial Concept]
   742   C1167518:core [Cell Component]
   742   C1272753:Institute [Idea or Concept]
   742   C1301820:Obtained [Functional Concept]
   742   C1706352:Core [Medical Device]
   742   C1709274:Northwest [Spatial Concept]
   742   C1882467:Core [Manufactured Object]
   742   C3274653:Core [Body Substance]
   708 E C1706701:Obtain [Activity]

Phrase: "("

Phrase: "provided by Dr. Christopher J. Rhodes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031831:DR [Professional or Occupational Group]
   753   C0454812:Rhodes [Geographic Area]
   753   C1707664:DR [Biomedical or Dental Material]
   753   C1999230:Provided [Activity]
   753   C2348314:Dr. [Conceptual Entity]
   753   C3540849:DR [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.69: HIT-T15 cells were subcultured for 72 h in 6-well culture plates, 1.25 x 106 cells/well. 

Phrase: "HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subcultured for 72 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0200940:Subculture [Laboratory Procedure]
   737   C0699799:subculture [Population Group]

Phrase: "in 6-well culture plates,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0180454:culture plates [Medical Device]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1139930:plates [Medical Device]
   812   C2242979:Culture [Laboratory Procedure]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]

Phrase: "1.25 x 106 cells/well."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C2347578:Cells/well [Quantitative Concept]
   799   C0007634:Cells [Cell]
   799   C0205170:Well [Qualitative Concept]
   799   C2827734:1+ [Quantitative Concept]
   799   C2981698:1+ [Classification]
   799   C3146287:Well [Manufactured Object]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.70: The cells were washed with RPMI media and infected with adenoviruses expressing either the PDX-1 or the MafA protein (from 0 to 5 x 109 pfu/well) for 2 h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with RPMI media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1548982:Washed [Idea or Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C0441648:Wash [Activity]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "infected with adenoviruses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0001483:Adenoviruses [Virus]
   790   C0439663:Infected [Functional Concept]
   756 E C0001486:Adenovirus [Disease or Syndrome]
   756 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "expressing"

Phrase: "either"

Phrase: "the PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "the MafA protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "from 0"

Phrase: "to 5 x 109 pfu/well"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1882406:PFU [Quantitative Concept]

Phrase: ")"

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.71: As a control, another set of cells was infected with the adenovirus expressing green fluorescent protein (GFP). 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "another"

Phrase: "set of cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
  1000   C0007634:Set of cells [Cell]
           Cells set
           Cells
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "infected with the adenovirus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0001483:Adenovirus, NOS [Virus]
   770   C0001486:Adenovirus [Disease or Syndrome]
   770   C0439663:Infected [Functional Concept]
   770   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "expressing"

Phrase: "green fluorescent protein (GFP)."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.72: The wells were washed with RPMI media followed by a 24-h culture period in media containing either 0.8 or 11.1 mM glucose. 

Phrase: "The wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "washed with RPMI media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1548982:Washed [Idea or Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C0441648:Wash [Activity]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "followed by a 24-h culture period"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0010453:Culture [Idea or Concept]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0220814:culture [Functional Concept]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0439531:/period [Temporal Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1948053:Period [Temporal Concept]
   748   C2242979:Culture [Laboratory Procedure]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either 0.8"

Phrase: "or"

Phrase: "11.1 mM glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.73: Insulin content and glucose-stimulated insulin secretion were measured in static incubations as described previously (13). 

Phrase: "Insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured in static incubations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0441463:Static [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.74: Whole cell extracts were obtained by harvesting cells as described above in lysis buffer containing 1x phosphatase inhibitor mixture set II (Calbiochem). 

Phrase: "Whole cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "obtained by harvesting cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737   C1512335:Harvest [Health Care Activity]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "as described above"

Phrase: "in lysis buffer containing 1x phosphatase inhibitor mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0439962:Mixture [Substance]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "II"

Phrase: "(Calbiochem"

Phrase: ")."
Processing 00000000.tx.75: Protein lysates were separated on 10% polyacrylamide Ready gels (Bio-Rad) and immunoblotted as described above to determine respective protein overexpression. 

Phrase: "Protein lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "separated on 10% polyacrylamide Ready gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   719 E C1382104:Gel [Substance]

Phrase: "(Bio-Rad)"

Phrase: "and"

Phrase: "immunoblotted as described above to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552738:described [Idea or Concept]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "determine"

Phrase: "respective protein overexpression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1514559:Protein Overexpression [Genetic Function]
           Overexpression
Processing 00000000.tx.76: Electromobility Shift Assay and Northern Blot AnalysisLate passage HIT-T15 cells were subcultured for 72 h in 100-mm culture plates, 4.5 x 106 cells/plate. 

Phrase: "Electromobility Shift Assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C0333051:Shift [Functional Concept]
   827   C1510438:Assay [Laboratory Procedure]
   827   C2347509:Shift [Phenomenon or Process]

Phrase: "and"

Phrase: "Northern Blot AnalysisLate passage HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subcultured for 72 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0200940:Subculture [Laboratory Procedure]
   737   C0699799:subculture [Population Group]

Phrase: "in 100-mm culture plates,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0180454:culture plates [Medical Device]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1139930:plates [Medical Device]
   812   C2242979:Culture [Laboratory Procedure]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]

Phrase: "4.5 x 106 cells/plate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1166718:cells plate [Cell Component]
   799   C0005971:Plate [Medical Device]
   799   C1139930:plate [Medical Device]
   799   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.77: The cells were washed with RPMI media and infected with GFP, PDX-1, MafA, or a combination of PDX-1 and MafA adenoviruses (3 x 1010 pfu/plate) for 2 h. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with RPMI media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1548982:Washed [Idea or Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C0441648:Wash [Activity]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "infected with GFP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0332583:Green [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]

Phrase: "PDX-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "MafA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "or"

Phrase: "a combination of PDX-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "MafA adenoviruses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0001483:Adenoviruses [Virus]
   827 E C0001486:Adenovirus [Disease or Syndrome]
   827 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(3 x 1010 pfu/plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005971:Plate [Medical Device]
   804   C1139930:plate [Medical Device]
   804   C3537155:Plate [Manufactured Object]

Phrase: ")"

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.78: The wells were washed with RPMI media followed by a 24-h culture period. 

Phrase: "The wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "were"

Phrase: "washed with RPMI media"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1548982:Washed [Idea or Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C0441648:Wash [Activity]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "followed by a 24-h culture period."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0010453:Culture [Idea or Concept]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0220814:culture [Functional Concept]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0439531:/period [Temporal Concept]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1948053:Period [Temporal Concept]
   748   C2242979:Culture [Laboratory Procedure]
   714 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.79: Nuclear extracts were prepared as described above. 

Phrase: "Nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   737   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.80: Electromobility shift assay was performed according to the method described by Olson et al. 

Phrase: "Electromobility shift assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C0333051:Shift [Functional Concept]
   827   C1510438:Assay [Laboratory Procedure]
   827   C2347509:Shift [Phenomenon or Process]

Phrase: "was"

Phrase: "performed according to the method"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0680240:according [Social Behavior]
   760   C0871511:METHOD [Intellectual Product]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described by Olson et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.81: (6). 

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.82: Total RNA was extracted and analyzed by Northern blot analysis as described above. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "analyzed by Northern blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   806   C1621557:Northern Blot [Research Device]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
           Analyzed
   760   C1524024:analysis [Functional Concept]
   760   C1709269:Northern [Spatial Concept]

Phrase: "as described above."
Processing 00000000.tx.83: The membrane was prehybridized for 1 h followed by a 16-h hybridization at 42 C with 32P-labeled Syrian hamster preproinsulin cDNA (15) and human -actin cDNA (16). 

Phrase: "The membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "prehybridized for 1 h"

Phrase: "followed by a 16-h hybridization"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0020202:Hybridisation [Genetic Function]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1300517:Hybridization [Laboratory Procedure]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "at 42 C"

Phrase: "with 32P-labeled Syrian hamster preproinsulin cDNA (15"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   818   C0018561:Syrian hamster [Mammal]
           Syrian
   795   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0018557:Hamster [Mammal]
   795   C0071928:Proinsulin, pre- [Amino Acid, Peptide, or Protein]
   795   C0337819:Syrian [Population Group]
   795   C1553631:32p [Medical Device]
   795   C1708632:Labeled [Qualitative Concept]
   762 E C0181496:Label [Manufactured Object]
   762 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: "and"

Phrase: "human -actin cDNA (16"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086418:Human [Human]
   741 E C0439681:Actinic [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.84: Two high stringency washes were performed at 50 C for 30 min. 

Phrase: "Two high stringency washes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0441648:Wash [Activity]

Phrase: "were"

Phrase: "performed at 50 C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.85: Detection of protein binding and mRNA levels was performed using the Cyclone storage phosphor system (Packard), and densitometry was performed using the OptiQuant image analysis software (Packard). 

Phrase: "Detection of protein binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Cyclone storage phosphor system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Packard"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the OptiQuant image analysis software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Packard"

Phrase: ")."
Processing 00000000.tx.86: StatisticsStatistical analysis was performed by unpaired Student's t test or analysis of variance where appropriate with significance set at p < 0.05.  

Phrase: "StatisticsStatistical analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed by unpaired Student's t test"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   820   C1710574:Unpaired t-Test [Intellectual Product]
   790   C1550369:Performed By [Qualitative Concept]
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:student [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0884358:Performed [Functional Concept]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]
   753   C2700112:Unpaired [Qualitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "or"

Phrase: "analysis of variance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "where appropriate with significance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1548787:Appropriate [Qualitative Concept]

Phrase: "set at p < 0.05."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]
Processing 00000000.tx.87: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Western and Northern Analyses for MafAMafA protein levels were measured in nuclear extracts from HIT-T15 cells (Fig. 1) using early passage (p7175; lane 1) and late passage (p123128; lane 2) cells chronically cultured in glucotoxic conditions (RPMI media containing 11.1 mM glucose). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "Northern Analyses for MafAMafA protein levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1514534:Protein Analysis [Molecular Biology Research Technique]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "measured in nuclear extracts"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   799   C1518434:Nuclear Extract [Biomedical or Dental Material]
   770   C0444706:Measured [Qualitative Concept]
   770   C0521447:Nuclear [Spatial Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737   C2828366:Extract [Substance]

Phrase: "from HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "early passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "(p7175"

Phrase: "; lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "late passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "(p123128"

Phrase: "; lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "cells chronically"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in glucotoxic conditions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   737   C0010453:Culture [Idea or Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0220814:culture [Functional Concept]
   737   C0348080:Condition [Qualitative Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C1705253:Condition [Conceptual Entity]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(RPMI media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "11.1 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.88: Late passage cells contained 3  1% MafA protein of that found in early passage cells (p < 0.0001). 

Phrase: "Late passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "3  1% MafA protein of that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "found in early passage cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0150312:Found [Quantitative Concept]
   760   C0439799:Passage [Spatial Concept]
   760   C1279919:Early [Temporal Concept]
   760   C3282337:Cells [Cell]
   726 E C0243095:Find [Finding]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(p < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.89: MafA mRNA levels were not different between early and late passage cells (55.3  4.0 versus 52.5  3.3 density light units (DLU), MafA/18 S, respectively; Fig. 2). 

Phrase: "MafA mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "not different between early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "late passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(55.3  4.0"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450382:55 [Intellectual Product]

Phrase: "versus"

Phrase: "52.5  3.3 density light units (DLU),"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "MafA/18 S,"

Phrase: "respectively"

Phrase: "; Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.90: Similar results were obtained using a mouse MafA cDNA +1to +360 probe (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mouse MafA cDNA +1to +360 probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0182400:Probe [Medical Device]
   799   C1704681:Probe [Gene or Genome]
   799   C2347609:Probe [Chemical Viewed Functionally]
   799   C3536729:Probe [Manufactured Object]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: View larger version (36K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.92: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.93: Loss of MafA protein in glucotoxic HIT-T15 cells. 

Phrase: "Loss of MafA protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "in glucotoxic HIT-T15 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.94: A representative Western blot analysis of nuclear extracts from HIT-T15 cells is shown. 

Phrase: "A representative Western blot analysis of nuclear extracts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1705493:Western [Spatial Concept]

Phrase: "from HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.95: Lane 1, early passage (p7175); 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "early passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "(p7175"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.96: lane 2, late passage (p123128) chronically cultured in 11.1 mM glucose. 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "late passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "(p123128"

Phrase: ")"

Phrase: "chronically"

Phrase: "cultured in 11.1 mM glucose."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1418486:MM-1 [Gene or Genome]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.97: Blots were probed with anti-MafA (47 kDa) and anti-TFIID (transcription factor class II D; 36 kDa) to control for protein loading. 

Phrase: "Blots"

Phrase: "were"

Phrase: "probed with anti-MafA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1416687:MAFA [Gene or Genome]
   770   C1427946:MAFA [Gene or Genome]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "(47 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "anti-TFIID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0076919:TFIID [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1337106:TFIID [Gene or Genome]

Phrase: "(transcription factor class II D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0033457:Factor D [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "; 36 kDa) to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "control for protein loading."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1708715:Loading [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.98: Results are also presented as mean  S.E.; 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "also"

Phrase: "presented as mean"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0444504:Mean [Quantitative Concept]
   790   C0449450:Presented [Idea or Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ";"
Processing 00000000.tx.99: data are averaged from densitometry of 46 blots (in DLU), *, p < 0.0001.  

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "averaged from densitometry of 46 blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011321:Densitometry [Laboratory Procedure]
   719   C1510992:Average [Quantitative Concept]
   719   C2825518:AVERAGE [Quantitative Concept]

Phrase: "("

Phrase: "in DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "*,"

Phrase: "p < 0.0001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.100: View larger version (74K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(74K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.101: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.102: MafA mRNA levels are normal in glucotoxic HIT-T15 cells. 

Phrase: "MafA mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "normal in glucotoxic HIT-T15 cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0007634:Normal cell [Cell]
   767   C1268443:Normal cell [Cell]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.103: Northern blot analysis for MafA mRNA in early passage cells (lanes 13) and late passage cells (lanes 46) was performed. 

Phrase: "Northern blot analysis for MafA mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005861:Northern blot analysis [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in early passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(lanes 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "late passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(lanes 46"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.104: The 18 S band is shown as a control for equal loading among the lanes. 

Phrase: "The 18 S band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "shown as a control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "for equal loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "among the lanes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.105: Results are also presented as mean  S.E.; 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "also"

Phrase: "presented as mean"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0444504:Mean [Quantitative Concept]
   790   C0449450:Presented [Idea or Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ";"
Processing 00000000.tx.106: data are averaged from densitometry of 3 blots (in DLU).  

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "averaged from densitometry of 3 blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011321:Densitometry [Laboratory Procedure]
   719   C1510992:Average [Quantitative Concept]
   719   C2825518:AVERAGE [Quantitative Concept]

Phrase: "("

Phrase: "in DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.107: Mechanism of Post-translational Regulation of MafATo examine post-translational mechanisms of MafA degradation, early passage cells were cultured with or without lactacystin, an irreversible proteasome inhibitor under 0.8 and 11.1 mM glucose conditions. 

Phrase: "Mechanism of Post-translational Regulation of MafATo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "examine"

Phrase: "post-translational mechanisms of MafA degradation,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "early passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured with"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0010453:Culture [Idea or Concept]
   799   C0220814:culture [Functional Concept]
   799   C0430400:Culture [Laboratory Procedure]
   799   C2242979:Culture [Laboratory Procedure]

Phrase: "or without lactacystin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "an irreversible proteasome inhibitor under 0.8"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   778   C2266856:Proteasome Inhibitor [Molecular Function]
   778   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1325620:proteasome [Cell Component]
   748   C1752727:Proteasome [Molecular Function]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "11.1 mM glucose conditions."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   771   C0012634:condition [Disease or Syndrome]
   771   C0348080:Condition [Qualitative Concept]
   771   C1705253:Condition [Conceptual Entity]
   721 E C0009647:Conditioned [Mental Process]
   721 E C1701901:Conditional [Qualitative Concept]
   721 E C1963686:Conditional [Functional Concept]
Processing 00000000.tx.108: The accumulation of MafA protein was augmented by the addition of the proteasome inhibitor in cells cultured both in 0.8 mM glucose (3147.3  380.3 versus 4812  617.2 DLU; no lactacystin versus lactacystin; p < 0.03, n = 4) and in 11.1 mM glucose (4468.3  659.7 versus 6712.8  1281.4 DLU; p < 0.04, n = 4; Fig. 3A), suggesting that degradation occurs via the proteasome pathway. 

Phrase: "The accumulation of MafA protein"

Phrase: "was"

Phrase: "augmented by the addition of the proteasome inhibitor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   770   C2266856:Proteasome Inhibitor [Molecular Function]
   770   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   744   C0205217:Augmented [Quantitative Concept]
   744   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1325620:proteasome [Cell Component]
   744   C1752727:Proteasome [Molecular Function]
   744   C1883712:Addition [Functional Concept]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "both in 0.8 mM glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0238767:Both [Spatial Concept]
   753   C1706086:Both [Qualitative Concept]

Phrase: "(3147.3  380.3"

Phrase: "versus"

Phrase: "4812  617.2 DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0439148:Units [Quantitative Concept]
   799   C1519795:Units [Quantitative Concept]
   766 E C1704753:Unit [Manufactured Object]
   766 E C1880519:Unit [Quantitative Concept]

Phrase: ";"

Phrase: "no lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "versus"

Phrase: "lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "; p < 0.03,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and in 11.1 mM glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1418486:MM-1 [Gene or Genome]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C1515981:And [Idea or Concept]

Phrase: "(4468.3  659.7"

Phrase: "versus"

Phrase: "6712.8  1281.4 DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "; p < 0.04,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 3A"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "occurs via the proteasome pathway."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   770 E C1523807:proteasomal pathway [Molecular Function]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1325620:proteasome [Cell Component]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.109: Immunoprecipitation of these cellular lysates with MafA antibody, followed by immunoblot analysis with antiubiquitin, indicated that MafA is ubiquitinated (Fig. 3B). 

Phrase: "Immunoprecipitation of these cellular lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with MafA antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by immunoblot analysis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "with antiubiquitin,"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "is"

Phrase: "ubiquitinated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.110: Interestingly, PDX-1 was also brought down with the MafA immunoprecipitation assay, indicating that a physical interaction exists between PDX-1 and MafA. 

Phrase: "Interestingly,"

Phrase: "PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "also"

Phrase: "brought down"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0332302:brought [Functional Concept]

Phrase: "with the MafA immunoprecipitation assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "indicating"

Phrase: "that"

Phrase: "a physical interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167622:Physical Interaction [Molecular Function]
   861   C1704675:Interaction [Functional Concept]

Phrase: "exists between PDX-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1826562:PDX-1 [Gene or Genome]
   770   C0332134:PDX [Qualitative Concept]
   770   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   770   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "MafA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]
Processing 00000000.tx.111: Furthermore, PDX-1 protein is also ubiquitinated (data not shown). 

Phrase: "Furthermore,"

Phrase: "PDX-1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "ubiquitinated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.112: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.113: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.114: Post-translational modification of MafA. 

Phrase: "Post-translational modification of MafA."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0033666:Post-Translational Modification [Molecular Function]
   760   C0392747:Modification [Functional Concept]
   760   C0687676:Post [Temporal Concept]
   760   C1519614:Translational [Genetic Function]
   760   C1554963:modification [Qualitative Concept]
   760   C1704687:Post [Manufactured Object]
Processing 00000000.tx.115: Western blot analyses of early passage HIT-T15 cells grown in either 0.8 or 11.1 mM glucose with or without lactacystin (10 M) were performed. 

Phrase: "Western blot analyses of early passage HIT-T15 cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   764   C0949466:Western Blot [Laboratory Procedure]
           Western blot analysis
   742   C1705493:Western [Spatial Concept]
   708   C0002778:Analysis [Laboratory Procedure]
   708   C0936012:Analysis [Research Activity]
   708   C1524024:analysis [Functional Concept]

Phrase: "grown in either 0.8"

Phrase: "or"

Phrase: "11.1 mM glucose with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or without lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(10"

Phrase: "M)"

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.116: A, lane 1, 0.8 mM; 

Phrase: "A,"

Phrase: "lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "0.8 mM"

Phrase: ";"
Processing 00000000.tx.117: lane 2, 0.8 mM + lactacystin; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "0.8 mM + lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.118: lane 3, 11.1 mM glucose; 

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "11.1 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.119: lane 4, 11.1 mM + lactacystin probed with anti-MafA. 

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "11.1 mM + lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "probed with anti-MafA."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1416687:MAFA [Gene or Genome]
   770   C1427946:MAFA [Gene or Genome]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.120: B, MafA immunoprecipitated protein complexes from cells grown in 0.8 mM (lane 1), 0.8 mM + lactacystin (lane 2), 11.1 mM glucose (lane 3), and 11.1 mM + lactacystin (lane 4) probed with anti-ubiquitin. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "protein complexes from cells"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   802   C1180347:complex protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799 E C1523872:protein complex [Cell Component]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1704241:Complexes [Chemical Viewed Structurally]
   737 E C0439855:Complex [Qualitative Concept]

Phrase: "grown in 0.8 mM (lane 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1418486:MM-1 [Gene or Genome]
   748   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "0.8 mM + lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "11.1 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "11.1 mM + lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "probed with anti-ubiquitin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.121: Representative blots from 3 experiments are shown.  

Phrase: "Representative blots from 3 experiments"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.122: Preventive Effect of N-Acetylcysteine (NAC) on the Loss of MafA Protein and MafA Binding to the Insulin Promoter in Cells Chronically Cultured in 11.1 mM GlucoseChronic culturing of HIT-T15 cells with NAC starting at passage 70 prevented the loss of MafA protein in nuclear extracts of late passage cells (0.687  0.20 DLU in 5 mM NAC-treated versus 0.189  0.10 DLU in untreated cells, p < 0.02, n = 45; Fig. 4). 

Phrase: "Preventive Effect of N-Acetylcysteine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "on the Loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of MafA Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "MafA Binding to the Insulin Promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1623517:insulin binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "in Cells Chronically"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Cultured in 11.1 mM GlucoseChronic culturing of HIT-T15 cells"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   754   C0007600:cultured cells [Cell]
   754   C0007635:Cultured Cells [Cell]
           cell culturing
   754   C1418486:MM-1 [Gene or Genome]
   754   C3282338:Cells, Cultured [Cell]
   738   C0007634:Cells [Cell]
   738   C0272285:HIT [Disease or Syndrome]
   738   C0332159:hit [Functional Concept]
   738   C1708373:Hit [Functional Concept]
   738   C3282337:Cells [Cell]
   737 E C0007585:cells culture [Laboratory Procedure]
   704   C0010453:Culture [Idea or Concept]
   704   C0220814:culture [Functional Concept]
   704   C0430400:Culture [Laboratory Procedure]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
   704   C2242979:Culture [Laboratory Procedure]

Phrase: "with NAC starting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439659:Start [Temporal Concept]
   734   C0001047:N-Acetyl Cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "at passage 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the loss of MafA protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "in nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "of late passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(0.687  0.20 DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "in 5 mM NAC-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332293:treated [Therapeutic or Preventive Procedure]
   804   C1522326:Treated [Functional Concept]
   771 E C1292734:TREAT [Functional Concept]

Phrase: "versus"

Phrase: "0.189  0.10 DLU in untreated cells,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C0439148:Units [Quantitative Concept]
   739   C1519795:Units [Quantitative Concept]
   706 E C1704753:Unit [Manufactured Object]
   706 E C1880519:Unit [Quantitative Concept]

Phrase: "p < 0.02,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 45"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.123: The level of MafA protein in the 5 mM NAC-treated late passage cells did not differ significantly from the early passage cells. 

Phrase: "The level of MafA protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0428479:Protein level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the 5 mM NAC-treated late passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ"

Phrase: "significantly from the early passage cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0439799:Passage [Spatial Concept]
   753   C1279919:Early [Temporal Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.124: Although treatment with 5 mM NAC was necessary to have a significant effect on protein levels, a concentration of 0.5 mM NAC was sufficient to significantly improve the amount of protein binding to the C1 element of the insulin promoter (0.90  0.12 versus 0.64  0.05 DLU in the untreated late passage cells, p < 0.05, n = 46; Fig. 5). 

Phrase: "Although"

Phrase: "treatment with 5 mM NAC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "necessary to"

Phrase: "have"

Phrase: "a significant effect on protein levels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "a concentration of 0.5 mM NAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "sufficient to significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205410:Sufficient [Qualitative Concept]

Phrase: "improve"

Phrase: "the amount of protein binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "to the C1 element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "of the insulin promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(0.90  0.12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]

Phrase: "versus"

Phrase: "0.64  0.05 DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "in the untreated late passage cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "p < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 46"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.125: Higher concentrations of NAC (1 and 5 mM) further augmented the amount of MafA binding (1.28  0.04 and 1.16  0.1 DLU, respectively, p < 0.0005 versus untreated). 

Phrase: "Higher concentrations of NAC"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "5 mM) further"

Phrase: "augmented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:Augmented [Quantitative Concept]

Phrase: "the amount of MafA binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(1.28  0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "1.16  0.1 DLU,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "respectively,"

Phrase: "p < 0.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: ")."
Processing 00000000.tx.126: View larger version (32K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.127: 4. 

Phrase: "4."
Processing 00000000.tx.128: NAC prevents the loss of MafA protein in late passage HIT-T15 cells chronically cultured in media containing 11.1 mM glucose. 

Phrase: "NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the loss of MafA protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "in late passage HIT-T15 cells chronically"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   841   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756   C2242979:Culture [Laboratory Procedure]
   756 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "11.1 mM glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.129: Upper panels, representative Western blot of HIT-T15 cell nuclear extracts from untreated early passage cells (lane 1) and late passage cells chronically cultured with NAC (0, 0.5, 1.0, or 5.0 mM, lanes 25). 

Phrase: "Upper panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "representative Western blot of HIT-T15 cell nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   764   C0949466:Western Blot [Laboratory Procedure]
   742   C1705493:Western [Spatial Concept]

Phrase: "from untreated early passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "late passage cells chronically"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "cultured with NAC"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0001047:acetylcysteine n [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]
   715 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(0,"

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "1.0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "5.0 mM,"

Phrase: "lanes 25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.130: Blots were probed with anti-MafA or anti-TFIID to control for loading. 

Phrase: "Blots"

Phrase: "were"

Phrase: "probed with anti-MafA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1416687:MAFA [Gene or Genome]
   770   C1427946:MAFA [Gene or Genome]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "anti-TFIID to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0076919:TFIID [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1337106:TFIID [Gene or Genome]

Phrase: "control for loading."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1708715:Loading [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.131: Lower panel, mean  S.E.; 

Phrase: "Lower panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: ";"
Processing 00000000.tx.132: *, p < 0.02 versus late passage with no NAC treatment data averaged from densitometry of 45 blots.  

Phrase: "*,"

Phrase: "p < 0.02"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "late passage with no NAC treatment data"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439799:Passage [Spatial Concept]

Phrase: "averaged from densitometry of 45 blots."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011321:Densitometry [Laboratory Procedure]
   719   C1510992:Average [Quantitative Concept]
   719   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.133: View larger version (46K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.134: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.135: NAC prevents the loss of MafA protein binding to the insulin promoter in late passage HIT-T15 cells chronically cultured in 11.1 mM glucose. 

Phrase: "NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the loss of MafA protein binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "to the insulin promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in late passage HIT-T15 cells chronically"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in 11.1 mM glucose."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1418486:MM-1 [Gene or Genome]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.136: Upper panel, representative electromobility shift assay of HIT-T15 cell nuclear protein binding to the C1 element of the insulin promoter in cells chronically cultured with NAC (0, 0.5, 1.0, or 5.0 mM). 

Phrase: "Upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "representative electromobility shift assay of HIT-T15 cell nuclear protein binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   738   C0005507:Assay [Laboratory Procedure]
   738   C0243073:assay [Qualitative Concept]
   738   C0333051:Shift [Functional Concept]
   738   C1510438:Assay [Laboratory Procedure]
   738   C2347509:Shift [Phenomenon or Process]

Phrase: "to the C1 element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "of the insulin promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in cells chronically"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured with NAC"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0001047:acetylcysteine n [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]
   715 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(0,"

Phrase: "0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "1.0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "5.0 mM"

Phrase: ")."
Processing 00000000.tx.137: Lane 1, untreated early passage cells and lanes 25, late passage cells cultured with 05.0 mM NAC. 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "untreated early passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "lanes 25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "late passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "cultured with 05.0 mM NAC."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0001047:acetylcysteine n [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.138: Lower panel, mean  S.E., data averaged from densitometry of 46 experiments, *, p < 0.05; 

Phrase: "Lower panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "averaged from densitometry of 46 experiments,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0011321:Densitometry [Laboratory Procedure]
   753   C0681814:Experiments [Research Activity]
   719   C1510992:Average [Quantitative Concept]
   719 E C1706386:Experiment [Conceptual Entity]
   719   C2825518:AVERAGE [Quantitative Concept]

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.139: **, p < 0.0001 versus late passage with no NAC treatment.  

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "versus"

Phrase: "late passage with no NAC treatment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439799:Passage [Spatial Concept]
Processing 00000000.tx.140: Transient Transfection with PDX-1 and MafA cDNAs and Insulin Reporter ActivityWestern blot analysis of HIT-T15 lysates revealed that the levels of PDX-1 and MafA proteins were increased 24 h following transfection with their respective cDNAs (Fig. 6) in both early and late passage cells. 

Phrase: "Transient Transfection with PDX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "MafA cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Insulin Reporter ActivityWestern blot analysis of HIT-T15 lysates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the levels of PDX-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0456947:Level 1 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "MafA proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "24 h"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "transfection with their respective cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "in both early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late passage cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.141: Insulin promoter activity was determined by measuring luciferase activity in HIT-T15 cells. 

Phrase: "Insulin promoter activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1145751:insulin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined by measuring luciferase activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C1151115:luciferase activity [Molecular Function]
   760   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0444706:measuring [Qualitative Concept]
   760   C0449770:measuring [Quantitative Concept]
   760   C1561536:*Activity [Idea or Concept]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "in HIT-T15 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.142: In agreement with our previous data (8), late passage cells grown in 11.1 mM glucose had diminished promoter activity as compared with early passage cells. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with our previous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "late passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "grown in 11.1 mM glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1418486:MM-1 [Gene or Genome]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "had"

Phrase: "diminished promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "compared with early passage cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0439799:Passage [Spatial Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.143: This decrease could be partially restored with PDX-1 (no PDX-1 = 34% of early passage; PDX-1 = 78% of early passage; Fig. 7A). 

Phrase: "This decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "partially"

Phrase: "restored with PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1826562:PDX-1 [Gene or Genome]
   770   C0332134:PDX [Qualitative Concept]
   770   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "no PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "= 34% of early passage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439799:Passage [Spatial Concept]
   770   C1279919:Early [Temporal Concept]

Phrase: "; PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "= 78% of early passage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439799:Passage [Spatial Concept]
   770   C1279919:Early [Temporal Concept]

Phrase: "; Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.144: Transfection with MafA cDNA also partially restored the level of promoter activity in glucotoxic cells (no MafA = 34% of early passage; MafA = 70% of early passage; Fig. 7B). 

Phrase: "Transfection with MafA cDNA also partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "restored"

Phrase: "the level of promoter activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0683317:Activity level [Finding]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in glucotoxic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "no MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "= 34% of early passage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439799:Passage [Spatial Concept]
   770   C1279919:Early [Temporal Concept]

Phrase: "; MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "= 70% of early passage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439799:Passage [Spatial Concept]
   770   C1279919:Early [Temporal Concept]

Phrase: "; Fig. 7B"

Phrase: ")."
Processing 00000000.tx.145: Co-transfection with both MafA and PDX-1 cDNAs completely restored insulin promoter activity to the levels observed in early passage cells (Fig. 7C). 

Phrase: "Co-transfection with both MafA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "PDX-1 cDNAs completely restored insulin promoter activity to the levels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   754   C0683317:activity levels [Finding]
   754   C1145751:insulin activity [Molecular Function]
   738   C0205177:Activity [Functional Concept]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1561536:*Activity [Idea or Concept]

Phrase: "observed in early passage cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0439799:Passage [Spatial Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 7C"

Phrase: ")."
Processing 00000000.tx.146: View larger version (23K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 6. 

Phrase: "6."
Processing 00000000.tx.148: Transfection with MafA and PDX-1 cDNAs increases their respective protein levels. 

Phrase: "Transfection with MafA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "PDX-1 cDNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "their respective protein levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.149: A representative Western blot of nuclear extracts from transfected HIT-T15 cells is shown. 

Phrase: "A representative Western blot of nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0949466:Western Blot [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]

Phrase: "from transfected HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.150: Lanes 14 from early passage cells (p7175); 

Phrase: "Lanes 14 from early passage cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0439799:Passage [Spatial Concept]
   753   C1279919:Early [Temporal Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719   C1708639:Lane [Spatial Concept]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(p7175"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.151: lanes 58 from late passage cells (p123128) grown in media containing 11.1 mM glucose. 

Phrase: "lanes 58 from late passage cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0205087:Late [Temporal Concept]
   753   C0439799:Passage [Spatial Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719   C1708639:Lane [Spatial Concept]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(p123128"

Phrase: ")"

Phrase: "grown in media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "11.1 mM glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.152: Lanes 1 and 5, transfected with CMV control; 

Phrase: "Lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "transfected with CMV control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.153: lanes 2 and 6, transfected with PDX-1; 

Phrase: "lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "6,"

Phrase: "transfected with PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1826562:PDX-1 [Gene or Genome]
   770   C0332134:PDX [Qualitative Concept]
   770   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.154: lanes 3 and 7, transfected with MafA; 

Phrase: "lanes 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "7,"

Phrase: "transfected with MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1416687:MAFA [Gene or Genome]
   790   C1427946:MAFA [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.155: lanes 4 and 8, transfected with Pdx-1 and MafA. 

Phrase: "lanes 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "8,"

Phrase: "transfected with Pdx-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1826562:PDX-1 [Gene or Genome]
   770   C0332134:PDX [Qualitative Concept]
   770   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "MafA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]
Processing 00000000.tx.156: Blots were probed with anti-MafA (47 kDa) (upper panel) and anti-Pdx-1 (46 kDa) (lower panel).  

Phrase: "Blots"

Phrase: "were"

Phrase: "probed with anti-MafA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1416687:MAFA [Gene or Genome]
   770   C1427946:MAFA [Gene or Genome]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "(47 kDa) (upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "anti-Pdx-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1826562:PDX-1 [Gene or Genome]
   827   C0332134:PDX [Qualitative Concept]
   827   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "(46 kDa) (lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.157: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 7. 

Phrase: "7."
Processing 00000000.tx.159: MafA and PDX-1 co-transfection completely restores insulin promoter activity. 

Phrase: "MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "and"

Phrase: "PDX-1 co-transfection completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "restores"

Phrase: "insulin promoter activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1145751:insulin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.160: Insulin promoter activity was measured by firefly luciferase activity corrected for transfection efficiency with pRL-CMV measured by Renilla luciferase activity in early passage (p7175) and late passage (p123128) cells chronically cultured in 11.1 mM glucose. 

Phrase: "Insulin promoter activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1145751:insulin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured by firefly luciferase activity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   862   C1324397:firefly luciferase activity [Molecular Function]
   806   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1151115:luciferase activity [Molecular Function]
   760   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0162328:Firefly [Eukaryote]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0444706:Measured [Qualitative Concept]
   760   C1561536:*Activity [Idea or Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "corrected for transfection efficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0013682:Efficiency [Quantitative Concept]
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C0205202:Corrected [Qualitative Concept]
   737 E C2349182:Correct [Qualitative Concept]

Phrase: "with pRL-CMV"

Phrase: "measured by Renilla luciferase activity"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C1151115:luciferase activity [Molecular Function]
   760   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0444706:Measured [Qualitative Concept]
   760   C1093003:Renilla [Eukaryote]
   760   C1561536:*Activity [Idea or Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "in early passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "(p7175"

Phrase: ")"

Phrase: "and"

Phrase: "late passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439799:Passage [Spatial Concept]

Phrase: "(p123128"

Phrase: ")"

Phrase: "cells chronically"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "cultured in 11.1 mM glucose."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1418486:MM-1 [Gene or Genome]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.161: A, transfection with CMV4 control (0 ng) or PDX-1 cDNA (12.5 or 25 ng); 

Phrase: "A,"

Phrase: "transfection with CMV4 control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "(0 ng)"

Phrase: "or"

Phrase: "PDX-1 cDNA (12.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1826562:PDX-1 [Gene or Genome]
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0332134:PDX [Qualitative Concept]
   804   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "25 ng"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.162: B, transfection with CMV4 control (0 ng) or MafA cDNA (12.5 or 25 ng); 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "transfection with CMV4 control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "(0 ng)"

Phrase: "or"

Phrase: "MafA cDNA (12.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416687:MAFA [Gene or Genome]
   812   C1427946:MAFA [Gene or Genome]

Phrase: "or"

Phrase: "25 ng"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.163: and panel C, transfection with CMV4 control (0 ng) or both MafA and PDX-1 cDNAs (12.5 or 25 ng of each) (n = 710, *, p < 0.05 late versus early).  

Phrase: "and"

Phrase: "panel C,"

Phrase: "transfection with CMV4 control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "(0 ng)"

Phrase: "or"

Phrase: "both MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "and"

Phrase: "PDX-1 cDNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "(12.5"

Phrase: "or"

Phrase: "25 ng of each"

Phrase: ")"

Phrase: "(n = 710,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "*,"

Phrase: "p < 0.05 late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205087:Late [Temporal Concept]

Phrase: "versus"

Phrase: "early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.164: Adenoviral Overexpression of PDX-1 and MafAWestern blot analysis indicated that the levels of PDX-1 and MafA proteins in late passage cells increased following infection with their respective adenoviruses with the greatest level of expression at 24 h (Fig. 8A). 

Phrase: "Adenoviral Overexpression of PDX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "MafAWestern blot analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the levels of PDX-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0456947:Level 1 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "MafA proteins in late passage cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "infection with their respective adenoviruses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0001486:Adenovirus infection [Disease or Syndrome]
   760   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "with the greatest level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "of expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "at 24 h (Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.165: Infection with the control GFP adenovirus did not affect the levels of PDX-1 or Maf A proteins as compared with uninfected cells (data not shown). 

Phrase: "Infection with the control GFP adenovirus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0001486:Adenovirus infection [Disease or Syndrome]
   767   C0085557:Infection Control [Health Care Activity]
   767   C1555984:Infection Control [Professional or Occupational Group]
   744   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the levels of PDX-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0456947:Level 1 [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "Maf"

Phrase: "A proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "compared with uninfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.166: The overexpressed proteins were functional as determined by their ability to bind to their respective sites on the insulin promoter (Fig. 8B). 

Phrase: "The overexpressed proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "as"

Phrase: "determined by their ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "bind to their respective sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205145:Sites [Spatial Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "on the insulin promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.167: Twenty-four hours after infection, the PDX-1 adenovirus increased protein binding to the A3 site of the insulin promoter 4.3  0.3-fold over the GFP-infected late passage cells (n = 3, p < 0.001). 

Phrase: "Twenty-four hours after infection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "the PDX-1 adenovirus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0001483:Adenovirus, NOS [Virus]
   827   C0001486:Adenovirus [Disease or Syndrome]
   827   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "protein binding to the A3 site"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0033618:Protein Binding [Molecular Function]
   783   C0005456:Binding Site [Receptor]
   783 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0682969:Binding Site [Amino Acid Sequence]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "of the insulin promoter 4.3  0.3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0332462:Fold [Spatial Concept]
   795   C1880834:FOLD [Phenomenon or Process]

Phrase: "over the GFP-infected late passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "(n = 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.168: Infection with the MafA adenovirus increased protein binding to the C1 site of the insulin promoter 7.7  0.8-fold over the GFP-infected cells (n = 3, p < 0.0001). 

Phrase: "Infection with the MafA adenovirus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0001486:Adenovirus infection [Disease or Syndrome]
   760   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "protein binding to the C1 site"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0033618:Protein Binding [Molecular Function]
   783   C0005456:Binding Site [Receptor]
   783 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0682969:Binding Site [Amino Acid Sequence]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "of the insulin promoter 7.7  0.8-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0332462:Fold [Spatial Concept]
   795   C1880834:FOLD [Phenomenon or Process]

Phrase: "over the GFP-infected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(n = 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "p < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.169: Infection with the GFP control adenovirus had no effect on endogenous PDX-1 or MafA protein binding to their respective insulin promoter elements as compared with uninfected cells (data not shown). 

Phrase: "Infection with the GFP control adenovirus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0001486:Adenovirus infection [Disease or Syndrome]
   767   C0085557:Infection Control [Health Care Activity]
   767   C1555984:Infection Control [Professional or Occupational Group]
   744   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "had"

Phrase: "no effect on endogenous PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "MafA protein binding to their respective insulin promoter elements"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   764   C0033618:Protein Binding [Molecular Function]
   762 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1623517:insulin binding [Molecular Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "as"

Phrase: "compared with uninfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.170: View larger version (30K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.171: 8. 

Phrase: "8."
Processing 00000000.tx.172: Infection with MafA and PDX-1 adenoviruses increases their protein levels and protein binding to their respective elements on the insulin promoter. 

Phrase: "Infection with MafA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0009450:Infection, NOS [Disease or Syndrome]
   718 E C0439663:Infected [Functional Concept]

Phrase: "and"

Phrase: "PDX-1 adenoviruses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0001483:Adenoviruses [Virus]
   793 E C0001486:Adenovirus [Disease or Syndrome]
   793 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "their protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0428479:Protein level [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "protein binding to their respective elements"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0033618:Protein Binding [Molecular Function]
   783 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "on the insulin promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.173: A representative Western blot of whole cell extracts from late passage HIT-T15 cells is shown. 

Phrase: "A representative Western blot of whole cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   778   C0949466:Western Blot [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]

Phrase: "extracts from late passage HIT-T15 cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   757   C0007592:Cell Extracts [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0205087:Late [Temporal Concept]
   748   C0272285:HIT [Disease or Syndrome]
   748   C0332159:hit [Functional Concept]
   748   C0439799:Passage [Spatial Concept]
   748   C1708373:Hit [Functional Concept]
   748   C2828366:Extract [Substance]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.174: A, upper panel, PDX-1-infected cells immunoblotted with anti-PDX-1 (46 kDa); 

Phrase: "A,"

Phrase: "upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "PDX-1-infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "immunoblotted with anti-PDX-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1826562:PDX-1 [Gene or Genome]
   760   C0332134:PDX [Qualitative Concept]
   760   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(46 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.175: lower panel, MafA-infected cells immunoblotted with anti-MafA (47 kDa). 

Phrase: "lower panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "MafA-infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "immunoblotted with anti-MafA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1416687:MAFA [Gene or Genome]
   770   C1427946:MAFA [Gene or Genome]
   737   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(47 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.176: The concentration of each adenovirus ranged from 0 to 5 x 109 pfu/well. 

Phrase: "The concentration of each adenovirus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "ranged from 0"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 5 x 109 pfu/well."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1882406:PFU [Quantitative Concept]
Processing 00000000.tx.177: B, a representative electromobility shift assay of nuclear extracts from late passage HIT-T15 cells infected with adenovirus at 3 x 1010 pfu/plate. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "a representative electromobility shift assay of nuclear extracts"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C0333051:Shift [Functional Concept]
   744   C1510438:Assay [Laboratory Procedure]
   744   C2347509:Shift [Phenomenon or Process]

Phrase: "from late passage HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "infected with adenovirus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001483:Adenovirus, NOS [Virus]
   790   C0001486:Adenovirus [Disease or Syndrome]
   790   C0439663:Infected [Functional Concept]
   790   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at 3 x 1010 pfu/plate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005971:Plate [Medical Device]
   804   C1139930:plate [Medical Device]
   804   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.178: Upper panel, protein binding to the A3 element of the insulin promoter. 

Phrase: "Upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "protein binding to the A3 element of the insulin promoter."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0033618:Protein Binding [Molecular Function]
   757 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1623517:insulin binding [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
Processing 00000000.tx.179: Lane 1, GFP-infected cells; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "GFP-infected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: ";"
Processing 00000000.tx.180: lane 2, PDX-1-infected cells; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "PDX-1-infected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.181: lower panel, protein binding to the C1 element of the insulin promoter. 

Phrase: "lower panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "protein binding to the C1 element of the insulin promoter."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0033618:Protein Binding [Molecular Function]
   757 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1623517:insulin binding [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
Processing 00000000.tx.182: Lane 1, GFP-infected cells; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "GFP-infected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: ";"
Processing 00000000.tx.183: lane 2, MafA-infected cells.  

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "MafA-infected cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.184: Insulin mRNA levels were measured by Northern blot analysis 24 h after adenoviral infection (Fig. 9). 

Phrase: "Insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0202098:insulin levels [Laboratory Procedure]
   913   C0428405:insulin levels [Laboratory or Test Result]
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by Northern blot analysis 24 h"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   814   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   778   C1621557:Northern Blot [Research Device]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0444706:Measured [Qualitative Concept]
   748   C0564385:/h [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1709269:Northern [Spatial Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "after adenoviral infection"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0851887:adenoviral infection [Disease or Syndrome]
   861   C0009450:Infection, NOS [Disease or Syndrome]
   789 E C0439663:Infected [Functional Concept]
   750 E C0030657:infectivity [Qualitative Concept]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.185: Infection of early passage cells with MafA and PDX-1 adenoviruses had no effect on insulin mRNA (A). 

Phrase: "Infection of early passage cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "with MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "and"

Phrase: "PDX-1 adenoviruses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0001483:Adenoviruses [Virus]
   793 E C0001486:Adenovirus [Disease or Syndrome]
   793 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "had"

Phrase: "no effect on insulin mRNA (A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.186: Late passage cells had significantly lower mRNA levels as compared with early passage cells (Fig. 9, B versus A, lane 1; 0.435  0.05 DLU versus 4.98  0.44, respectively, p < 0.001). 

Phrase: "Late passage cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "had"

Phrase: "significantly lower mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "compared with early passage cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0439799:Passage [Spatial Concept]
   760   C1279919:Early [Temporal Concept]
   760   C1707455:Compared [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "versus"

Phrase: "A,"

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "; 0.435  0.05 DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "versus"

Phrase: "4.98  0.44,"

Phrase: "respectively,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.187: Infection of late passage cells (Fig. 9, B and C) with the PDX-1 adenovirus increased insulin mRNA as compared with GFP-infected cells (174.2  11.6 versus 120.6  8.2 DLU, respectively, p < 0.009, n = 5). 

Phrase: "Infection of late passage cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "(Fig. 9,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C) with the PDX-1 adenovirus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1418485:C-1 [Gene or Genome]
   783   C3656770:Adenovirus C [Virus]
   753   C1553033:[c] [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "insulin mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as"

Phrase: "compared with GFP-infected cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   814   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0007634:Cells [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0332583:Green [Qualitative Concept]
   748   C0439663:Infected [Functional Concept]
   748   C1707455:Compared [Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(174.2  11.6"

Phrase: "versus"

Phrase: "120.6  8.2 DLU,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "respectively,"

Phrase: "p < 0.009,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.188: MafA plus PDX-1 overexpression further increased the level of insulin message to 232.8  16.7 DLU (p < 0.0001 as compared with GFP infection, n = 5). 

Phrase: "MafA plus PDX-1 overexpression further"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1514559:Overexpression [Genetic Function]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the level of insulin message"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0202098:Insulin level [Laboratory Procedure]
   797   C0428405:insulin level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "to 232.8  16.7 DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "(p < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "as"

Phrase: "compared with GFP infection,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   753   C0009450:Infection, NOS [Disease or Syndrome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0332583:Green [Qualitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.189: MafA overexpression alone increased the level of insulin mRNA but not to a statistically significant level (152.7  7.9 DLU, p < 0.09, n = 5). 

Phrase: "MafA overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the level of insulin mRNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0202098:Insulin level [Laboratory Procedure]
   797   C0428405:insulin level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "but"

Phrase: "not to a statistically significant level"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0237881:statistically significant [Quantitative Concept]
           significant
   783   C1273937:Not significant [Finding]
   754   C0814896:Significance Level [Research Activity]
   753   C0038215:Statistically [Occupation or Discipline]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C0750502:Significant [Idea or Concept]
   753   C1518422:Not [Functional Concept]
   753   C1546944:Significant [Qualitative Concept]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
   718 E C1709380:Statistical Significance [Quantitative Concept]

Phrase: "(152.7  7.9 DLU,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "p < 0.09,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.190: Cells overexpressing PDX-1 and MafA plus PDX-1 had glucose-dependent increases in insulin mRNA and content. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "MafA plus PDX-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1826562:PDX-1 [Gene or Genome]
   812   C0332134:PDX [Qualitative Concept]
   812   C0332287:Plus [Qualitative Concept]
   812   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   812   C1416687:MAFA [Gene or Genome]
   812   C1427946:MAFA [Gene or Genome]

Phrase: "had"

Phrase: "glucose-dependent increases in insulin mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0020459:INSULIN INCREASE [Disease or Syndrome]
   753   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.191: Cells infected with PDX-1 had insulin mRNA levels of 0.275  0.010 and 0.301  0.013 DLU (p < 0.05, n = 4) when cultured in the presence of 0.8 and 11.1 mM glucose, respectively. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with PDX-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1826562:PDX-1 [Gene or Genome]
   770   C0332134:PDX [Qualitative Concept]
   770   C0439663:Infected [Functional Concept]
   770   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "had"

Phrase: "insulin mRNA levels of 0.275  0.010"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0202098:insulin levels [Laboratory Procedure]
   767   C0428405:insulin levels [Laboratory or Test Result]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "0.301  0.013 DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "(p < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "when"

Phrase: "cultured in the presence of 0.8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "11.1 mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.192: Cells infected with MafA plus PDX-1 had insulin mRNA levels of 0.323  0.028 and 0.386  0.023 DLU (p < 0.02, n = 4) when cultured in the presence of 0.8 and 11.1 mM glucose. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with MafA plus PDX-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1826562:PDX-1 [Gene or Genome]
   753   C0332134:PDX [Qualitative Concept]
   753   C0332287:Plus [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   753   C1416687:MAFA [Gene or Genome]
   753   C1427946:MAFA [Gene or Genome]

Phrase: "had"

Phrase: "insulin mRNA levels of 0.323  0.028"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C0202098:insulin levels [Laboratory Procedure]
   767   C0428405:insulin levels [Laboratory or Test Result]
   744   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "0.386  0.023 DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "(p < 0.02,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "when"

Phrase: "cultured in the presence of 0.8"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "11.1 mM glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.193: The glucose-dependent increase in insulin mRNA caused by overexpression with MafA did not reach significance 0.262  0.011 and 0.300  0.044 DLU (p < 0.12, n = 4). 

Phrase: "The glucose-dependent increase in insulin mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0020459:INSULIN INCREASE [Disease or Syndrome]
   748   C0442805:Increase [Functional Concept]

Phrase: "caused by overexpression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1514559:Overexpression [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "with MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "significance 0.262  0.011"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0237881:Significance [Quantitative Concept]
   804   C0750502:Significance [Idea or Concept]
   733 E C1546944:Significant [Qualitative Concept]

Phrase: "and"

Phrase: "0.300  0.044 DLU"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0439148:Units [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "(p < 0.12,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n = 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.194: Insulin content was also significantly increased in cells overexpressing PDX-1 and MafA plus PDX-1 (1172.25  8.95 and 970.33  104.33 microunits/ml respectively, as compared with 451.67  76.12 microunits/ml in GFP-infected cells; p < 0.010.001; all n = 3). 

Phrase: "Insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "also significantly"

Phrase: "increased in cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "MafA plus PDX-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1826562:PDX-1 [Gene or Genome]
   812   C0332134:PDX [Qualitative Concept]
   812   C0332287:Plus [Qualitative Concept]
   812   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   812   C1416687:MAFA [Gene or Genome]
   812   C1427946:MAFA [Gene or Genome]

Phrase: "(1172.25  8.95"

Phrase: "and"

Phrase: "970.33  104.33 microunits/ml respectively,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0439526:/mL [Quantitative Concept]

Phrase: "as"

Phrase: "compared with 451.67  76.12 microunits/ml"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439526:/mL [Quantitative Concept]
   744   C1532565:Microunit [Quantitative Concept]
   744   C1707455:Compared [Activity]

Phrase: "in GFP-infected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "; p < 0.010.001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450300:0.010" [Quantitative Concept]
   812   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "all n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.195: MafA overexpression also resulted in an increase in insulin content (635.67  36.25 microunits/ml), although not significantly (p < 0.09). 

Phrase: "MafA overexpression also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514559:Overexpression [Genetic Function]

Phrase: "resulted in an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in insulin content"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(635.67  36.25 microunits/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "(p < 0.09"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.196: Static incubations of infected cells in 0.1 versus 0.8 mM glucose demonstrated increases of insulin secretion with the higher glucose concentration (data not shown), but the magnitudes of the increments were not different among the four infection conditions. 

Phrase: "Static incubations of infected cells"

Phrase: "in 0.1"

Phrase: "versus"

Phrase: "0.8 mM glucose demonstrated increases of insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0020459:INSULIN INCREASE [Disease or Syndrome]
   742   C0442805:increases [Functional Concept]

Phrase: "with the higher glucose concentration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   717   C0860803:high glucose [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the magnitudes of the increments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1704240:Magnitudes [Quantitative Concept]
   726 E C0449286:magnitude [Quantitative Concept]

Phrase: "were"

Phrase: "not different among the four infection conditions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.197: View larger version (48K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(48K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.198: 9. 

Phrase: "9."
Processing 00000000.tx.199: Infection with PDX-1 and MafA adenoviruses increases insulin mRNA levels in glucotoxic cells. 

Phrase: "Infection with PDX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0009450:Infection, NOS [Disease or Syndrome]

Phrase: "and"

Phrase: "MafA adenoviruses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0001483:Adenoviruses [Virus]
   827 E C0001486:Adenovirus [Disease or Syndrome]
   827 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "insulin mRNA levels in glucotoxic cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0202098:insulin levels [Laboratory Procedure]
   783   C0428405:insulin levels [Laboratory or Test Result]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.200: A and B show representative Northern blots of total RNA probed for insulin mRNA from early (A) and late (B) passage HIT-T15 cells infected with adenovirus at 3 x 1010 pfu/plate. 

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "representative Northern blots of total RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005861:northern blots [Molecular Biology Research Technique]
   790   C1621557:Northern Blots [Research Device]
   753   C1709269:Northern [Spatial Concept]

Phrase: "probed for insulin mRNA"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205087:Late [Temporal Concept]

Phrase: "(B) passage HIT-T15 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   897   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "infected with adenovirus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001483:Adenovirus, NOS [Virus]
   790   C0001486:Adenovirus [Disease or Syndrome]
   790   C0439663:Infected [Functional Concept]
   790   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at 3 x 1010 pfu/plate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005971:Plate [Medical Device]
   804   C1139930:plate [Medical Device]
   804   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.201: Lane 1, cells infected with GFP adenovirus; 

Phrase: "Lane 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with GFP adenovirus"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   783   C1332172:Adenovirus Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0001483:Adenovirus, NOS [Virus]
   753   C0001486:Adenovirus [Disease or Syndrome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0332583:Green [Qualitative Concept]
   753   C0439663:Infected [Functional Concept]
   753   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.202: lane 2, cells infected with PDX-1 adenovirus; 

Phrase: "lane 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with PDX-1 adenovirus"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1826562:PDX-1 [Gene or Genome]
   760   C0001483:Adenovirus, NOS [Virus]
   760   C0001486:Adenovirus [Disease or Syndrome]
   760   C0332134:PDX [Qualitative Concept]
   760   C0439663:Infected [Functional Concept]
   760   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   760   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.203: lane 3, cells infected with MafA adenovirus; 

Phrase: "lane 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with MafA adenovirus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001483:Adenovirus, NOS [Virus]
   770   C0001486:Adenovirus [Disease or Syndrome]
   770   C0439663:Infected [Functional Concept]
   770   C1416687:MAFA [Gene or Genome]
   770   C1427946:MAFA [Gene or Genome]
   770   C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.204: lane 4, cells infected with both MafA and PDX-1 adenoviruses. 

Phrase: "lane 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "infected with both MafA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439663:Infected [Functional Concept]
   770   C1416687:MAFA [Gene or Genome]
   770   C1427946:MAFA [Gene or Genome]

Phrase: "and"

Phrase: "PDX-1 adenoviruses."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0001483:Adenoviruses [Virus]
   793 E C0001486:Adenovirus [Disease or Syndrome]
   793 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1826562:PDX-1 [Gene or Genome]
Processing 00000000.tx.205: C shows late passage insulin mRNA levels corrected for 18 S, mean  S.E., data averaged from densitometry of 5 blots, *, p < 0.05; 

Phrase: "C"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "late passage insulin mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   853   C0202098:insulin levels [Laboratory Procedure]
   853   C0428405:insulin levels [Laboratory or Test Result]
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "corrected for 18 S,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0205202:Corrected [Qualitative Concept]
   737 E C2349182:Correct [Qualitative Concept]

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "averaged from densitometry of 5 blots,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011321:Densitometry [Laboratory Procedure]
   719   C1510992:Average [Quantitative Concept]
   719   C2825518:AVERAGE [Quantitative Concept]

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.206: **, p < 0.001.   

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.207: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The recent identification of RIPE-3b1 as MafA (1012) enabled us to perform the studies described in this report. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The recent identification of RIPE-3b1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "as MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "(1012"

Phrase: ")"

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "described in this report."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C1552738:described [Idea or Concept]
   770   C3273238:Report [Intellectual Product]
Processing 00000000.tx.208: We show that, as with PDX-1, MafA protein is virtually absent in glucotoxic HIT-T15 cells. 

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "as with PDX-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1826562:PDX-1 [Gene or Genome]
   770   C0332134:PDX [Qualitative Concept]
   770   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "MafA protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "virtually absent in glucotoxic HIT-T15 cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:Absent [Quantitative Concept]
   748   C2699517:ABSENT [Finding]
Processing 00000000.tx.209: However, in contrast to the decrease in the level of PDX-1 mRNA, MafA mRNA levels remain normal in glucotoxic cells, suggesting post-translational modification of the protein. 

Phrase: "However,"

Phrase: "in contrast to the decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "in the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of PDX-1 mRNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "MafA mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "remain"

Phrase: "normal in glucotoxic cells,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C0007634:Normal cell [Cell]
   802   C1268443:Normal cell [Cell]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "post-translational modification of the protein."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   851   C0033666:Protein Modification, Post-Translational [Molecular Function]
           Post-Translational Modification
           Protein Modification
   814   C1449566:Protein Modification, Translational [Molecular Function]
   783   C2263112:protein modification [Molecular Function]
   753   C0392747:Modification [Functional Concept]
   753   C0687676:Post [Temporal Concept]
   753   C1519614:Translational [Genetic Function]
   753   C1554963:modification [Qualitative Concept]
   753   C1704687:Post [Manufactured Object]
   748   C0597295:Protein Translation [Molecular Function]
Processing 00000000.tx.210: In the current study, we show that MafA protein is ubiquitinated and that blocking the proteasomal pathway with lactacystin leads to an accumulation of MafA. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that MafA protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "ubiquitinated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the proteasomal pathway with lactacystin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C1523807:proteasomal pathway [Molecular Function]
   770 E C1752727:Proteasome Pathway [Molecular Function]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "leads to an accumulation of MafA."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C1416687:MAFA [Gene or Genome]
   753   C1427946:MAFA [Gene or Genome]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.211: The antioxidant, NAC, which prevents disappearance of PDX-1 in glucotoxic states (17), also prevented loss of MafA protein and its binding to the insulin promoter in these cells. 

Phrase: "The antioxidant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "NAC,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "which"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "disappearance of PDX-1"

Phrase: "in glucotoxic states"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "(17"

Phrase: ")"

Phrase: ","

Phrase: "also prevented loss of MafA protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "its binding to the insulin promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1623517:insulin binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "in these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.212: Furthermore, transient transfection with either transcription factor improved defective insulin promoter activity, and transfection with both fully restored this activity. 

Phrase: "Furthermore,"

Phrase: "transient transfection with either transcription factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "defective insulin promoter activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C1145751:insulin activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "transfection with both fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "restored"

Phrase: "this activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.213: Combined adenoviral overexpression of PDX-1 and MafA partially restored endogenous insulin gene expression and insulin content in glucotoxic HIT-T15 cells. 

Phrase: "Combined adenoviral overexpression of PDX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "MafA partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416687:MAFA [Gene or Genome]
   861   C1427946:MAFA [Gene or Genome]

Phrase: "restored"

Phrase: "endogenous insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0017262:Gene Expression [Genetic Function]
   861   C1337112:Insulin Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "insulin content in glucotoxic HIT-T15 cells."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0030281:Insulin Cell [Cell]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.214: Maf proteins are a family of transcription factors that are key regulators in cellular differentiation. 

Phrase: "Maf proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0919482:Maf Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "a family of transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015576:Family [Family Group]
   760   C1704727:Family [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "key regulators in cellular differentiation."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0182953:regulators [Medical Device]
   726 E C1704734:Regulator [Medical Device]
   726 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.215: The oncoprotein v-Maf (musculoaponeurotic fibrosarcoma) was the first identified member of the Maf family (18). 

Phrase: "The oncoprotein v-Maf (musculoaponeurotic fibrosarcoma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0016057:Fibrosarcoma [Neoplastic Process]

Phrase: ")"

Phrase: "was"

Phrase: "the first identified member of the Maf family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0086282:Family member [Family Group]
   767   C1611821:Family Member [Intellectual Product]
   744   C0680022:member [Population Group]
   744   C2698041:Member [Professional or Occupational Group]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.216: These transcription factors all contain a conserved basic leucine zipper (bZIP) domain necessary for their dimerization and DNA binding properties. 

Phrase: "These transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "all"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a conserved basic leucine zipper"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1515557:Basic Leucine Zipper [Amino Acid Sequence]
   861   C0079686:Leucine Zipper [Amino Acid, Peptide, or Protein]
   812   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0453984:Zipper [Manufactured Object]

Phrase: "(bZIP) domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1515557:bZIP Domain [Amino Acid Sequence]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "necessary for their dimerization"

Phrase: "and"

Phrase: "DNA binding properties."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]
   734   C1148673:DNA Binding [Genetic Function]
Processing 00000000.tx.217: Three members are referred to as small Mafs: MafG, MafF, and MafK. 

Phrase: "Three members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680022:members [Population Group]
   827 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "small Mafs"

Phrase: ":"

Phrase: "MafG,"

Phrase: "MafF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416967:MAFF [Gene or Genome]

Phrase: "and"

Phrase: "MafK."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416968:MAFK [Gene or Genome]
Processing 00000000.tx.218: The additional four large Maf members are c-Maf, MafB, neural retina leucine zipper, and MafA (L-Maf), which have a well conserved N-terminal transactivation domain. 

Phrase: "The additional four large Maf members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0680022:members [Population Group]
   771 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "c-Maf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919481:c-MAF [Gene or Genome]

Phrase: "MafB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416710:MAFB [Gene or Genome]
  1000   C1565054:MAFB [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "neural retina leucine zipper,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C1417848:NEURAL RETINA LEUCINE ZIPPER [Gene or Genome]
   861   C0079686:Leucine Zipper [Amino Acid, Peptide, or Protein]
   861   C1518263:Neural Retina [Body Part, Organ, or Organ Component]
   812   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0035298:Retina [Body Part, Organ, or Organ Component]
   812   C0453984:Zipper [Manufactured Object]
   812   C0599851:Neural [Functional Concept]
   812   C1278894:Retina [Body Part, Organ, or Organ Component]
   756 E C0027740:Nerve [Tissue]
   756 E C0027757:NERVE [Tissue]
   756 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   719 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "MafA (L-Maf),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "which"

Phrase: "have"

Phrase: "a well conserved N-terminal transactivation domain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0040624:Transactivation [Genetic Function]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.219: The MafA gene was originally isolated from avian neuroretina cells (19) and recently identified in pancreatic islets (10, 11, 20, 21). 

Phrase: "The MafA gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1427946:MAFA gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "originally"

Phrase: "isolated from avian neuroretina cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0005595:Avian [Bird]
   760   C0007634:Cells [Cell]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C0370215:Isolate [Substance]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(19"

Phrase: ")"

Phrase: "and"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "identified in pancreatic islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "(10,"

Phrase: "11,"

Phrase: "20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.220: Within the islet, MafA is localized to the beta cell, whereas expression of MafB (12) and c-Maf (21) is limited to the alpha cell. 

Phrase: "Within the islet,"

Phrase: "MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "is"

Phrase: "localized to the beta cell,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0030281:Beta cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0330390:Beta [Plant]
   760   C0392752:Localized [Spatial Concept]
   760   C0439096:Beta [Intellectual Product]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2004068:Beta [Qualitative Concept]

Phrase: "whereas"

Phrase: "expression of MafB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(12"

Phrase: ")"

Phrase: "and"

Phrase: "c-Maf (21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0919481:c-MAF [Gene or Genome]
   827   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "limited to the alpha cell."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0030280:Alpha cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0439095:Alpha [Intellectual Product]
   760   C0439801:Limited [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2003941:Alpha [Intellectual Product]
   760   C2350010:Alpha [Qualitative Concept]
   760   C3542948:Limited [Intellectual Product]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.221: Furthermore, MafA has been found to be required for the formation and development of mature islet beta cells (20). 

Phrase: "Furthermore,"

Phrase: "MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "required for the formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1514873:Required [Functional Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "development of mature islet beta cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   803   C3155114:mature cell development [Cell Function]
   783   C0815089:cells development [Cell Function]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.222: Regulation of the insulin gene by MafA (11, 12, 20, 22) occurs via binding to the RIPE-3b1/C1 element of the insulin promoter, which is similar to the binding sequence referred to as Maf-recognition element(MARE). 

Phrase: "Regulation of the insulin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0017263:Gene Regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "by MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "(11,"

Phrase: "12,"

Phrase: "20,"

Phrase: "22"

Phrase: ")"

Phrase: "occurs via binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "to the RIPE-3b1/C1 element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C1705248:Element [Conceptual Entity]

Phrase: "of the insulin promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "is"

Phrase: "similar to the binding sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1710052:Sequence Similarity [Quantitative Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "Maf-recognition element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C1705248:Element [Conceptual Entity]

Phrase: "(MARE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0019944:Mare [Mammal]
  1000   C1422420:MARE [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.223: Loss of this essential activator of insulin gene transcription greatly compromises insulin gene expression. 

Phrase: "Loss of this essential activator of insulin gene transcription greatly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1517945:Loss [Quantitative Concept]

Phrase: "compromises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "insulin gene expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.224: We have proposed that chronic oxidative stress is an important mechanism for glucose toxicity (17). 

Phrase: "We"

Phrase: "have"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that chronic oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "an important mechanism for glucose toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.225: Treatment of Zucker diabetic fatty rats (5) and db/db mice (4) with NAC protected against the progression of type 2 diabetes. 

Phrase: "Treatment of Zucker diabetic fatty rats"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "db/db mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(4"

Phrase: ")"

Phrase: "with NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "protected against the progression of type 2 diabetes."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0011860:Type 2 Diabetes [Disease or Syndrome]
   770   C0441730:Type 2 [Classification]
   767   C1320657:Diabetes type [Finding]
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
   744   C0242656:progression [Pathologic Function]
   744   C0332307:Type [Qualitative Concept]
   744   C0449258:Progression [Functional Concept]
   744   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.226: Performance of molecular studies designed to examine mechanisms of glucose toxicity is not possible with isolated islets because they do not withstand chronic cultures over many months. 

Phrase: "Performance of molecular studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597198:Performance [Individual Behavior]
   770   C1882330:Performance [Activity]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "mechanisms of glucose toxicity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "not possible with isolated islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332149:Possible [Qualitative Concept]
   760   C1705910:Possible [Qualitative Concept]
   760   C2362652:Possible [Qualitative Concept]

Phrase: "because"

Phrase: "they"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "withstand"

Phrase: "chronic cultures over many months."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0010453:Cultures [Idea or Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.227: Therefore, we have used HIT-T15 cells cultured under high glucose concentrations for periods up to 1 year. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "have"

Phrase: "used HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "cultured under high glucose concentrations"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   806   C0860803:high glucose [Finding]
   797   C0427743:concentrations glucose [Laboratory Procedure]
   797   C1287281:concentrations glucose [Laboratory or Test Result]
   781   C0680299:high culture [Population Group]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0086045:Concentrations [Mental Process]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C1446561:Concentration [Quantitative Concept]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "for periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   966   C0439531:/period [Temporal Concept]
   966   C1948053:Period [Temporal Concept]
   916 E C0332182:Periodic [Temporal Concept]
   916 E C1706381:PERIODIC [Intellectual Product]
   893 E C0031084:Periodicities [Temporal Concept]

Phrase: "up to 1 year."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439234:year [Temporal Concept]
   861   C0439508:/year [Temporal Concept]
Processing 00000000.tx.228: In all respects, this beta cell line reproduces the losses in PDX-1, MafA, insulin mRNA, insulin content, and glucose-induced insulin secretion that have been found in animal models. 

Phrase: "In all respects,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679133:respects [Social Behavior]

Phrase: "this beta cell line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007600:Cell Line [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   734   C0030281:Beta cell [Cell]

Phrase: "reproduces"

Phrase: "the losses in PDX-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1517945:Loss [Quantitative Concept]

Phrase: "MafA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "insulin mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "insulin content,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "found in animal models."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0599779:Models, Animal [Animal]
   770   C0003062:Animal [Animal]
   770   C0150312:Found [Quantitative Concept]
   770   C3161035:Models [Intellectual Product]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.229: For example, NAC prevented the loss of insulin message and promoter activity and significantly improved glucose-stimulated insulin secretion in late passage HIT-T15 cells chronically cultured with media containing 11.1 mM glucose (5). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the loss of insulin message"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "significantly improved glucose-stimulated insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   839   C1719133:Glucose/Insulin [Quantitative Concept]
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in late passage HIT-T15 cells chronically"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "cultured with media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   841   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   790   C0009458:Media [Intellectual Product]
   790   C0162867:Media [Tissue]
   790   C1254021:Media [Tissue]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756 E C0439536:Medium [Quantitative Concept]
   756 E C1705217:Medium [Substance]
   756   C2242979:Culture [Laboratory Procedure]
   756 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "11.1 mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.230: Loss of PDX-1 protein and decreased binding to the insulin promoter could be prevented by culturing cells with NAC (17). 

Phrase: "Loss of PDX-1 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "decreased binding to the insulin promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1623517:insulin binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "could"

Phrase: "be"

Phrase: "prevented by culturing cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   802   C0007585:cells culture [Laboratory Procedure]
   802   C0007635:cell culturing [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0309872:PREVENT [Pharmacologic Substance]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "with NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.231: In the current study, we show that NAC also has beneficial effects on MafA by preserving protein expression and binding to the insulin promoter. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that NAC also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0001047:N-Acetyl Cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   771 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "has"

Phrase: "beneficial effects on MafA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "by preserving protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "binding to the insulin promoter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1623517:insulin binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
Processing 00000000.tx.232: This finding is consistent with the observation that MafA binding to the human insulin promoter can be abolished with oxidizing agents (23) and further supports the role of oxidative stress as a mechanism for glucose toxicity. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is"

Phrase: "consistent with the observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that MafA binding to the human insulin promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1623517:insulin binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]

Phrase: "can"

Phrase: "be"

Phrase: "abolished with oxidizing agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0085403:Oxidizing Agents [Chemical Viewed Functionally]
   737   C0030011:oxidize [Molecular Function]
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the role of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "as a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "for glucose toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.233: Complete recovery of insulin promoter activity with the combined transient overexpression of PDX-1 and MafA supports our hypothesis that both factors were required for normal activity. 

Phrase: "Complete recovery of insulin promoter activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2826210:Complete Recovery [Finding]
   753   C0237820:Recovery [Activity]
   753   C1555688:recovery [Idea or Concept]
   753   C2004454:Recovery [Organism Function]

Phrase: "with the combined transient overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514559:Overexpression [Genetic Function]

Phrase: "of PDX-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "both factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "were"

Phrase: "required for normal activity."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205177:Activity [Functional Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1514873:Required [Functional Concept]
   770   C1561536:*Activity [Idea or Concept]
   770   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.234: However, the incomplete recovery of endogenous insulin message in the adenoviral infection studies suggests that a greater duration of exposure to overexpressed proteins may be needed for full restoration of insulin mRNA and/or that other factors involved in insulin transcription may also be diminished in glucotoxic cells. 

Phrase: "However,"

Phrase: "the incomplete recovery of endogenous insulin message"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0237820:Recovery [Activity]
   748   C1555688:recovery [Idea or Concept]
   748   C2004454:Recovery [Organism Function]

Phrase: "in the adenoviral infection studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0851887:adenoviral infection [Disease or Syndrome]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a greater duration of exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2826870:Exposure Duration [Temporal Concept]
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "to overexpressed proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "needed for full restoration of insulin mRNA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0027552:Needed [Qualitative Concept]
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0443225:Full [Qualitative Concept]
   748   C0449982:Restoration [Intellectual Product]
   748   C0686904:needed [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and/or"

Phrase: "that"

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "involved in insulin transcription"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0040649:Transcription [Genetic Function]
   770   C1314939:Involved [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "diminished in glucotoxic cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205216:Diminished [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.235: Prior to recognizing the RIPE-3b1 activator as MafA, cooperativity between proteins binding to the RIPE3a and RIPE3b elements had been observed (24, 25). 

Phrase: "Prior to recognizing"

Phrase: "the RIPE-3b1 activator as MafA,"

Phrase: "cooperativity between proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0679729:cooperative [Organization]

Phrase: "binding to the RIPE3a"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "RIPE3b elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "had"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.236: Homo- and heterodimers formed between Mafs and other basic leucine zipper factors (for a review, see Ref. 26) can lead to positive or negative transcriptional regulation depending on the combination. 

Phrase: "Homo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300203:Homo [Mammal]
  1000   C3245470:HOMO [Finding]

Phrase: "and"

Phrase: "heterodimers"

Phrase: "formed between Mafs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0205431:Formed [Functional Concept]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]
   756 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "other basic leucine zipper factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
   756   C1515557:Basic Leucine Zipper [Amino Acid Sequence]

Phrase: "("

Phrase: "for a review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "can"

Phrase: "lead to positive"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0439178:% Positive [Quantitative Concept]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1446409:Positive [Qualitative Concept]
   790   C1514241:Positive [Finding]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C2825490:Positive [Qualitative Concept]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "negative transcriptional regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1158770:Transcriptional Regulation [Genetic Function]
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]

Phrase: "depending on the combination."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]
   737   C0725813:depend [Medical Device]
Processing 00000000.tx.237: The small Maf proteins, as homo- or heterodimers, can bind to Maf-recognition elements and act as transcriptional repressors (27). 

Phrase: "The small Maf proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0919482:Maf Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "homo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300203:Homo [Mammal]
  1000   C3245470:HOMO [Finding]

Phrase: "or"

Phrase: "heterodimers,"

Phrase: "can"

Phrase: "bind to Maf-recognition elements"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0013879:Elements [Element, Ion, or Isotope]
   760   C0524637:Recognition [Mental Process]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   726 E C1705248:Element [Conceptual Entity]

Phrase: "and"

Phrase: "act as transcriptional repressors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C1336789:Transcriptional Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Repressor
   770   C0040649:Transcriptional [Genetic Function]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.238: Since oxidative stress has been shown to induce the levels of MafG (28), it is possible that these small Mafs may also have an effect on insulin gene regulation. 

Phrase: "Since"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the levels of MafG"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "these small Mafs"

Phrase: "may"

Phrase: "also"

Phrase: "have"

Phrase: "an effect on insulin gene regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.239: Alternatively, proteins interfering with positive regulators may facilitate the down-regulation of the insulin gene (29). 

Phrase: "Alternatively,"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interfering with positive regulators"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0182953:regulators [Medical Device]
   770   C0439178:% Positive [Quantitative Concept]
   770   C0521102:interfering [Qualitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]
   737 E C1704734:Regulator [Medical Device]
   737 E C1704735:Regulator [Conceptual Entity]

Phrase: "may"

Phrase: "facilitate"

Phrase: "the down-regulation of the insulin gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0920533:Gene Down-Regulation [Genetic Function]
   778   C0013081:Down-Regulation [Cell Function,Molecular Function]
   774   C0017263:Gene Regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.240: Beta cells exposed to high glucose levels have increased gene expression of Id-1 and Id-3 (30) and up-regulated CCAAT/enhancer-binding protein/ levels (31), all of which can negatively affect insulin gene expression (31, 32). 

Phrase: "Beta cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0030281:Beta cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to high glucose levels"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   806   C0428548:glucose levels [Laboratory or Test Result]
   806   C0860803:high glucose [Finding]
   773 E C0337438:glucose level [Laboratory Procedure]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "have"

Phrase: "increased gene expression of Id-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017262:Gene Expression [Genetic Function]
   783   C1706509:Gene ID [Intellectual Product]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Id-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: "(30"

Phrase: ")"

Phrase: "and"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "CCAAT/enhancer-binding protein/ levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0428479:Protein level [Laboratory or Test Result]
   804   C0441889:Levels [Qualitative Concept]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "can"

Phrase: "negatively"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "insulin gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1337112:Insulin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.241: This inhibition is likely due to their interference with E47 homodimer or heterodimer formation (29). 

Phrase: "This inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is"

Phrase: "likely due to their interference"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0332148:Likely [Qualitative Concept]
   760   C0521102:Interference [Qualitative Concept]
   760   C0750492:Likely [Idea or Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "with E47 homodimer"

Phrase: "or"

Phrase: "heterodimer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.242: In conclusion, the recent identification of RIPE-3b1 as MafA has allowed us to now demonstrate that protein levels of this insulin gene transcription factor are virtually absent in glucotoxic beta cells. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "the recent identification of RIPE-3b1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "as MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "has"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to now"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1948052:Now [Temporal Concept]

Phrase: "demonstrate"

Phrase: "that protein levels of this insulin gene transcription factor"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   762   C0202098:insulin levels [Laboratory Procedure]
   762   C0428405:insulin levels [Laboratory or Test Result]
   762   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441889:Levels [Qualitative Concept]
   731   C0428479:Protein level [Laboratory or Test Result]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "virtually absent in glucotoxic beta cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]
Processing 00000000.tx.243: In contrast to the transcription defect leading to PDX-1 protein loss, this work indicates that the defect leading to MafA protein loss is post-translational. 

Phrase: "In contrast to the transcription defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "leading to PDX-1 protein loss,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C1826562:PDX-1 [Gene or Genome]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332134:PDX [Qualitative Concept]
   753   C0332152:Leading [Temporal Concept]
   753   C0879404:PDX [Organic Chemical,Pharmacologic Substance]
   753   C1517945:Loss [Quantitative Concept]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "indicates"

Phrase: "that"

Phrase: "the defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1457869:Defect [Functional Concept]
  1000   C1861101:DEFECT [Disease or Syndrome]

Phrase: "leading to MafA protein loss"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332152:Leading [Temporal Concept]
   760   C1416687:MAFA [Gene or Genome]
   760   C1427946:MAFA [Gene or Genome]
   760   C1517945:Loss [Quantitative Concept]
   760   C1522538:Leading [Functional Concept]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "post-translational."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0687676:Post [Temporal Concept]
   861   C1519614:Translational [Genetic Function]
   861   C1704687:Post [Manufactured Object]
   789 E C0040712:Translation [Intellectual Product]
   789 E C0597295:translation [Molecular Function]
   789 E C1514253:Postal [Functional Concept]
Processing 00000000.tx.244: MafA is ubiquitinated, and blocking the proteasomal pathway with lactacystin resulted in an increase in MafA protein levels. 

Phrase: "MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "is"

Phrase: "ubiquitinated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ","

Phrase: "and"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the proteasomal pathway with lactacystin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C1523807:proteasomal pathway [Molecular Function]
   770 E C1752727:Proteasome Pathway [Molecular Function]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "resulted in an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442805:Increase [Functional Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in MafA protein levels."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.245: Combined transient transfection of PDX-1 and MafA completely normalizes insulin promoter activity, and combined adenoviral overexpression of PDX-1 and MafA increases endogenous insulin gene expression in glucotoxic HIT-T15 cells. 

Phrase: "Combined transient transfection of PDX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "MafA completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416687:MAFA [Gene or Genome]
   861   C1427946:MAFA [Gene or Genome]

Phrase: "normalizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "insulin promoter activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1145751:insulin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "combined adenoviral overexpression of PDX-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "MafA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "endogenous insulin gene expression in glucotoxic HIT-T15 cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0017262:Gene Expression [Genetic Function]
   764   C1337112:Insulin Gene [Gene or Genome]
   745   C1861886:CELL Gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.246: That NAC prevents the loss of both MafA and PDX-1 proteins and their binding to the insulin promoter in glucotoxic HIT-T15 cells supports our hypothesis that chronic oxidative stress is a central mechanism for glucotoxicity and beta cell dysfunction.  

Phrase: "That NAC"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the loss of both MafA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "PDX-1 proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1826562:PDX-1 [Gene or Genome]

Phrase: "and"

Phrase: "their binding to the insulin promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1623517:insulin binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "in glucotoxic HIT-T15 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that chronic oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "a central mechanism for glucotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "beta cell dysfunction."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C1969875:Beta-cell dysfunction [Finding]
   827   C0031847:dysfunction [Functional Concept]
   827   C0277785:Dysfunction, NOS [Qualitative Concept]
   771 E C0231174:Malfunction [Functional Concept]
   771 E C1881681:MALFUNCTION [Phenomenon or Process]
   734   C0030281:Beta cell [Cell]
Processing 00000000.tx.247: FOOTNOTES  * This work was supported by National Institutes of Health Grant RO1 DK 38325 (to R. P. R.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institutes of Health Grant RO1 DK 38325"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   739   C0011318:DK [Geographic Area]
   739   C0018173:Grant [Quantitative Concept]
   739   C0018684:Health [Idea or Concept]
   739   C0021622:Institutes [Organization]
   739   C1521721:Supported [Conceptual Entity]
   739   C1548284:Grant [Idea or Concept]
   739   C3245503:national [Intellectual Product]
   706 E C0183683:Support [Medical Device]
   706 E C1272753:Institute [Idea or Concept]

Phrase: "("

Phrase: "to R. P. R."

Phrase: ")."
Processing 00000000.tx.248: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.249: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.250: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.251: || To whom correspondence should be addressed: Pacific Northwest Research Institute, 720 Broadway, Seattle, WA 98122. 

Phrase: "||"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Pacific Northwest Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035172:Research Institute [Organization]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]

Phrase: "720 Broadway,"

Phrase: "Seattle,"

Phrase: "WA 98122."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]
Processing 00000000.tx.252: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.253: 206-726-1210; 

Phrase: "206-726-1210"

Phrase: ";"
Processing 00000000.tx.254: Fax: 206-726-1217; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "206-726-1217"

Phrase: ";"
Processing 00000000.tx.255: E-mail: rpr{at}pnri.org . 1 The abbreviations used are: PDX-1, pancreatic/duodenal homeobox-1; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "rpr{at}pnri.org . 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1522486:ORG [Professional or Occupational Group]
   804   C1705631:RPR [Gene or Genome]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PDX-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1826562:PDX-1 [Gene or Genome]
   861   C0332134:PDX [Qualitative Concept]
   861   C0879404:PDX [Organic Chemical,Pharmacologic Substance]

Phrase: "pancreatic/duodenal homeobox-1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0013303:Duodenal [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0242303:Homeo Box [Gene or Genome]
   812   C0598306:Homeo Box [Spatial Concept]
   741 E C1278921:Duodenum [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.256: RIPE-3b1, rat insulin promoter element; 

Phrase: "RIPE-3b1,"

Phrase: "rat insulin promoter element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C1705248:Element [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.257: MafA, mammalian homologue of avian MafA/L-Maf; 

Phrase: "MafA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: "mammalian homologue of avian MafA/L-Maf"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1334043:Homologue [Gene or Genome]

Phrase: "L-Maf"

Phrase: "L-Maf"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416687:MAFA [Gene or Genome]
  1000   C1427946:MAFA [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.258: LUC, luciferase; 

Phrase: "LUC,"

Phrase: "luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: ";"
Processing 00000000.tx.259: NAC, N-acetyl-L-cysteine; 

Phrase: "NAC,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0001047:N-Acetylcysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   805 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "N-acetyl-L-cysteine"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001047:N-Acetyl-L-cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           N-Acetyl Cysteine
           Acetyl cysteine
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: ";"
Processing 00000000.tx.260: DLU, density light units; 

Phrase: "DLU,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: "density light units"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.261: GFP, green fluorescent protein; 

Phrase: "GFP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.262: pfu, plaque-forming units; 

Phrase: "pfu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882406:PFU [Quantitative Concept]

Phrase: "plaque-forming units"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C1882406:PLAQUE-FORMING UNITS [Quantitative Concept]
   827   C0011389:Plaque [Disease or Syndrome]
   827   C0205431:Forming [Functional Concept]
   827   C0332461:Plaque [Finding]
   827   C0333463:plaque [Acquired Abnormality]
   827   C0439148:Units [Quantitative Concept]
   827   C1519795:Units [Quantitative Concept]
   827   C1522492:Forming [Functional Concept]
   793 E C0348078:Form [Qualitative Concept]
   793 E C0376315:Form [Manufactured Object]
   793 E C1704753:Unit [Manufactured Object]
   793 E C1880519:Unit [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.263: CMV, cytomegalovirus; 

Phrase: "CMV,"

Phrase: "cytomegalovirus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010825:Cytomegalovirus [Virus]

Phrase: ";"
Processing 00000000.tx.264: INS, insulin.  

Phrase: "INS,"

Phrase: "insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.265: ACKNOWLEDGMENTS  We thank Elizabeth Oseid for expert technical assistance, Dr. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Elizabeth Oseid for expert technical assistance,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.266: Christopher J. 

Phrase: "Christopher J."
Processing 00000000.tx.267: Rhodes, Pacific Northwest Research Institute, for the adenoviral constructs, Dr. 

Phrase: "Rhodes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454812:Rhodes [Geographic Area]

Phrase: "Pacific Northwest Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035172:Research Institute [Organization]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]

Phrase: "for the adenoviral constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.268: Danielle Melloul, Hadassah University Hospital, for the gift of INS-LUC, and Dr. 

Phrase: "Danielle Melloul,"

Phrase: "Hadassah University Hospital,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "for the gift"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0423899:Gifted [Finding]

Phrase: "of"

Phrase: "INS-LUC,"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.269: Chris Wright, Vanderbilt University, for the gift of PDX-1 antiserum.  

Phrase: "Chris Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "Vanderbilt University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "for the gift"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0423899:Gifted [Finding]

Phrase: "of PDX-1 antiserum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C1826562:PDX-1 [Gene or Genome]
Processing 00000000.tx.270: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Yki-Jarvinen, H. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Yki-Jarvinen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.271: (1992) Endocr. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Endocr."
Processing 00000000.tx.272: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.273: 13, 415431[Medline] [OrderarticleviaInfotrieve] Eizirik, D. 

Phrase: "13,"

Phrase: "415431"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Eizirik,"

Phrase: "D."
Processing 00000000.tx.274: L., Korbutt, G. 

Phrase: "L., Korbutt,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.275: S., and Hellerstrom, C. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Hellerstrom,"

Phrase: "C."
Processing 00000000.tx.276: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.277: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.278: Investig. 

Phrase: "Investig."
Processing 00000000.tx.279: 90, 12631268[Medline] [OrderarticleviaInfotrieve] Robertson, R. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "12631268"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.280: P., Zhang, H.-J., Pyzdrowski, K. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "H.-J.,"

Phrase: "Pyzdrowski,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.281: L., and Walseth, T. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Walseth,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.282: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.283: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.284: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.285: Investig. 

Phrase: "Investig."
Processing 00000000.tx.286: 90, 320325[Medline] [OrderarticleviaInfotrieve] Kaneto, H., Kajimoto, Y., Miyagawa, J.-i., Matsuoka, T.-a., Fujitani, Y., Umayahara, Y., Hanafusa, T., Matsuzawa, Y., Yamasaki, Y., and Hori, M. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "320325"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kaneto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kajimoto,"

Phrase: "Y.,"

Phrase: "Miyagawa,"

Phrase: "J.-i.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Matsuoka,"

Phrase: "T.-a.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Fujitani,"

Phrase: "Y.,"

Phrase: "Umayahara,"

Phrase: "Y.,"

Phrase: "Hanafusa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsuzawa,"

Phrase: "Y.,"

Phrase: "Yamasaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Hori,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.287: (1999) Diabetes 48, 23982406[Abstract] Tanaka, Y., Gleason, C. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Diabetes 48,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "23982406"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tanaka,"

Phrase: "Y.,"

Phrase: "Gleason,"

Phrase: "C."
Processing 00000000.tx.288: E., Tran, P. 

Phrase: "E.,"

Phrase: "Tran,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.289: O. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.290: T., Harmon, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harmon,"

Phrase: "J."
Processing 00000000.tx.291: S., and Robertson, R. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.292: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.293: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.294: Natl. 

Phrase: "Natl."
Processing 00000000.tx.295: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.296: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.297: U. 

Phrase: "U."
Processing 00000000.tx.298: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.299: A. 

Phrase: "A."
Processing 00000000.tx.300: 96, 1085710862[Abstract/Free FullText] Olson, L. 

Phrase: "96,"

Phrase: "1085710862"

Phrase: "[Abstract/Free FullText"

Phrase: "] Olson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.301: K., Redmon, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Redmon,"

Phrase: "J."
Processing 00000000.tx.302: B., Towle, H. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Towle,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.303: C., and Robertson, R. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.304: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.305: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.306: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.307: Investig. 

Phrase: "Investig."
Processing 00000000.tx.308: 92, 514519[Medline] [OrderarticleviaInfotrieve] Poitout, V., Olson, L. 

Phrase: "92,"

Phrase: "514519"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Poitout,"

Phrase: "V.,"

Phrase: "Olson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.309: K., and Robertson, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.310: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.311: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.312: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.313: Investig. 

Phrase: "Investig."
Processing 00000000.tx.314: 97, 10411046[Abstract/Free FullText] Harmon, J. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "10411046"

Phrase: "[Abstract/Free FullText"

Phrase: "] Harmon,"

Phrase: "J."
Processing 00000000.tx.315: S., Tanaka, Y., Olson, L. 

Phrase: "S."

Phrase: ","

Phrase: "Tanaka,"

Phrase: "Y.,"

Phrase: "Olson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.316: K., and Robertson, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.317: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.318: (1998) Diabetes 47, 900904[Abstract] Samaras, S. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Diabetes 47,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "900904"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Samaras,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.319: E., Zhao, L., Means, A., Henderson, E., Matsuoka, T.-a., and Stein, R. 

Phrase: "E.,"

Phrase: "Zhao,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Means,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "A.,"

Phrase: "Henderson,"

Phrase: "E.,"

Phrase: "Matsuoka,"

Phrase: "T.-a.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Stein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.320: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.321: Biol. 

Phrase: "Biol."
Processing 00000000.tx.322: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.323: 278, 1226312270[Abstract/Free FullText] Olbrot, M., Rud, J., Moss, L. 

Phrase: "278,"

Phrase: "1226312270"

Phrase: "[Abstract/Free FullText"

Phrase: "] Olbrot,"

Phrase: "M."

Phrase: ","

Phrase: "Rud,"

Phrase: "J.,"

Phrase: "Moss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282635:Moss [Plant]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.324: G., and Sharma, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sharma,"

Phrase: "A."
Processing 00000000.tx.325: (2002) Proc. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.326: Natl. 

Phrase: "Natl."
Processing 00000000.tx.327: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.328: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.329: U. 

Phrase: "U."
Processing 00000000.tx.330: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.331: A. 

Phrase: "A."
Processing 00000000.tx.332: 99, 67376742[Abstract/Free FullText] Kataoka, K., Han, S.-i., Shioda, S., Hirai, M., Nishizawa, M., and Handa, H. 

Phrase: "99,"

Phrase: "67376742"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kataoka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "S.-i.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Shioda,"

Phrase: "S."

Phrase: ","

Phrase: "Hirai,"

Phrase: "M."

Phrase: ","

Phrase: "Nishizawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Handa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.333: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.334: Biol. 

Phrase: "Biol."
Processing 00000000.tx.335: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.336: 277, 4990349910[Abstract/Free FullText] Matsuoka, T.-a., Zhao, L., Artner, I., Jarrett, H. 

Phrase: "277,"

Phrase: "4990349910"

Phrase: "[Abstract/Free FullText"

Phrase: "] Matsuoka,"

Phrase: "T.-a.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Zhao,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Artner,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jarrett,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.337: W., Friedman, D., Means, A., and Stein, R. 

Phrase: "W., Friedman,"

Phrase: "D."

Phrase: ","

Phrase: "Means,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "A.,"

Phrase: "and"

Phrase: "Stein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.338: (2003) Mol. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.339: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.340: Biol. 

Phrase: "Biol."
Processing 00000000.tx.341: 23, 60496062[Abstract/Free FullText] Zhang, H.-J., Walseth, T. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "60496062"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang,"

Phrase: "H.-J.,"

Phrase: "Walseth,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.342: F., and Robertson, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.343: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.344: (1989) Diabetes 38, 4448[Abstract] Schreiber, E., Matthias, P., Muller, M. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Diabetes 38,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "4448"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schreiber,"

Phrase: "E.,"

Phrase: "Matthias,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Muller,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.345: M., and Schaffner, W. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Schaffner,"

Phrase: "W."
Processing 00000000.tx.346: (1989) Nucleic Acids Res. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.347: 17, 6419[Medline] [OrderarticleviaInfotrieve] Bell, G. 

Phrase: "17,"

Phrase: "6419"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.348: I., and Sanchez-Pescador, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Sanchez-Pescador,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.349: (1984) Diabetes 33, 297300[Abstract] Gunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H., and Kedes, L. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Diabetes 33,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "297300"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gunning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018397:gun [Manufactured Object]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ponte,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Okayama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Engel,"

Phrase: "J.,"

Phrase: "Blau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1826449:BLAU [Gene or Genome]
  1000   C2698415:BLAU [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kedes,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.350: (1983) Mol. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.351: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.352: Biol. 

Phrase: "Biol."
Processing 00000000.tx.353: 3, 787795[Medline] [OrderarticleviaInfotrieve] Robertson, R. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "787795"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Robertson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.354: P., Harmon, J., Tran, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Harmon,"

Phrase: "J.,"

Phrase: "Tran,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.355: O., Tanaka, Y., and Takahashi, H. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Tanaka,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.356: (2003) Diabetes 52, 581587[Abstract/Free FullText] Nishizawa, M., Kataoka, K., Goto, N., Fujiwara, K. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Diabetes 52,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "581587"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nishizawa,"

Phrase: "M."

Phrase: ","

Phrase: "Kataoka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Goto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Fujiwara,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.357: T., and Kawai, S. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Kawai,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.358: (1989) Proc. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.359: Natl. 

Phrase: "Natl."
Processing 00000000.tx.360: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.361: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.362: U. 

Phrase: "U."
Processing 00000000.tx.363: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.364: A. 

Phrase: "A."
Processing 00000000.tx.365: 86, 77117715[Abstract] Benkhelifa, S., Provot, S., Lecoq, O., Pouponnot, C., Calothy, G., and Felder-Schmittbuhl, M.-P. 

Phrase: "86,"

Phrase: "77117715"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Benkhelifa,"

Phrase: "S."

Phrase: ","

Phrase: "Provot,"

Phrase: "S."

Phrase: ","

Phrase: "Lecoq,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Pouponnot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Calothy,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Felder-Schmittbuhl,"

Phrase: "M.-"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.366: (1998) Oncogene 17, 247254[CrossRef][Medline] [OrderarticleviaInfotrieve] Matsuoka, T.-a., Artner, I., Henderson, E., Means, A., Sander, M., and Stein, R. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Oncogene 17,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "247254"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Matsuoka,"

Phrase: "T.-a.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Artner,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Henderson,"

Phrase: "E.,"

Phrase: "Means,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "A.,"

Phrase: "Sander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504648:Sander [Fish]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Stein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.367: (2004) Proc. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.368: Natl. 

Phrase: "Natl."
Processing 00000000.tx.369: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.370: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.371: U. 

Phrase: "U."
Processing 00000000.tx.372: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.373: A. 

Phrase: "A."
Processing 00000000.tx.374: 101, 29302933[Abstract/Free FullText] Kataoka, K., Shioda, S., Ando, K., Sakagami, K., Handa, H., and Yasuda, K. 

Phrase: "101,"

Phrase: "29302933"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kataoka,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shioda,"

Phrase: "S."

Phrase: ","

Phrase: "Ando,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sakagami,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Handa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Yasuda,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.375: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.376: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.377: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.378: 32, 920[Abstract/Free FullText] Kajihara, M., Sone, H., Amemiya, M., Katoh, Y., Isogai, M., Shimano, H., Yamada, N., and Takahashi, S. 

Phrase: "32,"

Phrase: "920"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kajihara,"

Phrase: "M."

Phrase: ","

Phrase: "Sone,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564199:Sone [Pharmacologic Substance,Steroid]
  1000   C1825500:SONE [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Amemiya,"

Phrase: "M."

Phrase: ","

Phrase: "Katoh,"

Phrase: "Y.,"

Phrase: "Isogai,"

Phrase: "M."

Phrase: ","

Phrase: "Shimano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamada,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.379: (2003) Biochem. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.380: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.381: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.382: Commun. 

Phrase: "Commun."
Processing 00000000.tx.383: 312, 831842[CrossRef][Medline] [OrderarticleviaInfotrieve] Read, M. 

Phrase: "312,"

Phrase: "831842"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Read, M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.384: L., Masson, M. 

Phrase: "L., Masson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.385: R., and Docherty, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Docherty,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.386: (1997) FEBS Lett. 

Phrase: "(1997"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.387: 418, 6872[CrossRef][Medline] [OrderarticleviaInfotrieve] Hwung, Y.-P., Gu, Y.-Z., and Tsai, M.-J. 

Phrase: "418,"

Phrase: "6872"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hwung,"

Phrase: "Y.-P.,"

Phrase: "Gu,"

Phrase: "Y.-Z.,"

Phrase: "and"

Phrase: "Tsai,"

Phrase: "M.-"

Phrase: "J."
Processing 00000000.tx.388: (1990) Mol. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.389: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.390: Biol. 

Phrase: "Biol."
Processing 00000000.tx.391: 10, 17841788[Medline] [OrderarticleviaInfotrieve] Shieh, S.-Y., and Tsai, M.-J. 

Phrase: "10,"

Phrase: "17841788"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shieh,"

Phrase: "S.-"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Tsai,"

Phrase: "M.-"

Phrase: "J."
Processing 00000000.tx.392: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.393: Biol. 

Phrase: "Biol."
Processing 00000000.tx.394: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.395: 266, 1670816714[Abstract/Free FullText] Blank, V., and Andrews, N. 

Phrase: "266,"

Phrase: "1670816714"

Phrase: "[Abstract/Free FullText"

Phrase: "] Blank,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750479:blank [Finding]

Phrase: "V.,"

Phrase: "and"

Phrase: "Andrews,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.396: C. 

Phrase: "C."
Processing 00000000.tx.397: (1997) Trends Biochem. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.398: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.399: 22, 437441[CrossRef][Medline] [OrderarticleviaInfotrieve] Motohashi, H., Shavit, J. 

Phrase: "22,"

Phrase: "437441"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Motohashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shavit,"

Phrase: "J."
Processing 00000000.tx.400: A., Igarashi, K., Yamamoto, M., and Engel, J. 

Phrase: "A.,"

Phrase: "Igarashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Engel,"

Phrase: "J."
Processing 00000000.tx.401: D. 

Phrase: "D."
Processing 00000000.tx.402: (1997) Nucleic Acids Res. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.403: 25, 29532959[Abstract/Free FullText] Crawford, D. 

Phrase: "25,"

Phrase: "29532959"

Phrase: "[Abstract/Free FullText"

Phrase: "] Crawford,"

Phrase: "D."
Processing 00000000.tx.404: R., Leahy, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Leahy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.405: P., Wang, Y., Schools, G. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "Y.,"

Phrase: "Schools,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036375:Schools [Manufactured Object,Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.406: P., Kochheiser, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kochheiser,"

Phrase: "J."
Processing 00000000.tx.407: C., and Davies, K. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Davies,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.408: J. 

Phrase: "J."
Processing 00000000.tx.409: (1996) Free Radic. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.410: Biol. 

Phrase: "Biol."
Processing 00000000.tx.411: Med. 

Phrase: "Med."
Processing 00000000.tx.412: 21, 521525[CrossRef][Medline] [OrderarticleviaInfotrieve] Melloul, D., Marshak, S., and Cerasi, E. 

Phrase: "21,"

Phrase: "521525"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Melloul,"

Phrase: "D."

Phrase: ","

Phrase: "Marshak,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Cerasi,"

Phrase: "E."
Processing 00000000.tx.413: (2002) Diabetologia 45, 309326[CrossRef][Medline] [OrderarticleviaInfotrieve] Wice, B. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Diabetologia 45,"

Phrase: "309326"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wice,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.414: M., Bernal-Mizrachi, E., and Permutt, M. 

Phrase: "M."

Phrase: ","

Phrase: "Bernal-Mizrachi,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Permutt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.415: A. 

Phrase: "A."
Processing 00000000.tx.416: (2001) Diabetologia 44, 453463[CrossRef][Medline] [OrderarticleviaInfotrieve] Seufert, J., Weir, G. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Diabetologia 44,"

Phrase: "453463"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Seufert,"

Phrase: "J.,"

Phrase: "Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.417: C., and Habener, J. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Habener,"

Phrase: "J."
Processing 00000000.tx.418: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.419: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.420: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.421: Investig. 

Phrase: "Investig."
Processing 00000000.tx.422: 101, 25282539[Abstract/Free FullText] Cordle, S. 

Phrase: "101,"

Phrase: "25282539"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cordle,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.423: R., Henderson, E., Masuoka, H., Weil, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Henderson,"

Phrase: "E.,"

Phrase: "Masuoka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Weil,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.424: A., and Stein, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Stein,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.425: (1991) Mol. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.426: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.427: Biol. 

Phrase: "Biol."
Processing 00000000.tx.428: 11, 17341738[Medline] [OrderarticleviaInfotrieve]

Phrase: "11,"

Phrase: "17341738"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

